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 I investigated strategies for reducing Varroa mite populations (Varroa destructor) 
in honey bee colonies (Apis mellifera) using oxalic acid (OA).  I examined the efficacy of 
OA in both broodless colonies and colonies that contain brood.  My data indicate that OA 
is most effective at reducing Varroa populations when colonies are broodless because 
repeated applications of OA did not significantly reduce mite populations in colonies 
when brood was present.  Next, I quantified the contact toxicity of OA to Varroa mites 
and their honey bee hosts in laboratory bioassays.  The results indicate that OA has a low 
acute toxicity to honey bees and a high acute toxicity to mites.  The toxicity data will help 
guide scientists in delivering lethal dosages of OA to the parasite and in protecting its 
host. 
I also investigated how OA is distributed in honey bee colonies when applied 
using the trickle method.  For this study, I constructed nine divided Langstroth hives 
using 3 different types of dividers that allowed trophallaxis, physical contact, or 
fumigation.  I treated bees on one side of the divider and then monitored mite mortality 
on both the treated and untreated sides.  Bee-to-bee contact was the primary route for OA 
distribution.  Finally, I developed a protocol for using OA to eliminate mites from 
package bees.  I made 97 packages of Varroa-infested adult bees.  I sprayed an OA 
solution directly on the bees through the mesh screen of the package cages using a 
pressurized air brush.  I quantified mite and bee mortality and estimated the optimum 
dosage of OA to apply to package bees for mite control without injuring bees.  The 
application of 3 mL of a 2.8% OA sugar water solution per 1000 bees will allow 
beekeepers to safely reduce populations of Varroa mites from packages prior to 
  
installation.  My research is significant because it offers beekeepers a safe, effective, and 
sustainable method for reducing Varroa populations.   
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1  
Introduction 
 
 Varroa jacobsoni was first described by Oudemans in 1904 as a natural 
ectoparasitic mite of the Eastern honey bee, Apis cerana F.  Recently, Anderson and 
Trueman (2000) reported that V. jacobsoni is a complex of 2 different species that 
parasitize A. cerana.  The original species, V. jacobsoni, encompasses 9 haplotypes that 
infest A. cerana in the Malaysia-Indonesia region.  In contrast, the newly described 
species, Varroa destructor, includes 6 haplotypes that infest A. cerana on mainland Asia.  
Adult females of V. destructor are larger and less spherical than females of V. jacobsoni, 
and the 2 species are reproductively isolated (Anderson and Trueman 2002).   
Movement of the European honey bee, Apis mellifera L. into areas where A. 
cerana is endemic let V. destructor transfer to A. mellifera, a far less resistant host (De 
Jong et al. 1982).  V. destructor found on A. cerana in Asia exhibit commensalism, a 
host-parasite relationship that is advantageous to V. destructor but does not negatively 
affect A. cerana (Büchler 1994, Boecking et al. 1998).  In contrast, A. mellifera colonies 
infested with V. destructor usually die in 3-5 years without beekeeper intervention (De 
Jong et al. 1982).   
Since the discovery of V. destructor (Varroa) in the United States in 1987 
(Anonymous 1987), the feral population of honey bees has dramatically declined (Kraus 
and Page 1995, Harbo and Hoopingarner 1997).  Managed honey bee colonies have also 
been severely injured (Sammataro 1997, Martin 2001).  Furthermore, Varroa has added 
considerable labor and expense to the cost of managing honey bees (Ellis 2001, Sanford 
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2001).  Varroa is generally considered the most severe threat to beekeeping worldwide 
(De Jong 1990, Beetsma 1994, Martin 1998, Anderson & Trueman 2000). 
Currently, 8 chemical treatments are registered in the United States to control 
Varroa mites: 1) Apistan® (fluvalinate), 2) CheckMite+® (coumaphos), 3) Mite-Away 
II® (formic acid), 4) Apicure® (formic acid), 5) Apiguard® (thymol), 6) ApiLife-Var® 
(blend of thymol, eucalyptol, menthol, and camphor), 7) Sucrocide® (sucrose octanoate), 
and 8) Hivastan® (fenpyroximate).  Apistan® has been used extensively for Varroa 
control, achieving nearly 100% efficacy in susceptible mite populations (Faucon et al. 
1995).  Apistan® is sold in plastic strips impregnated with fluvalinate that are suspended 
between frames in the brood chamber for 6-8 weeks.  They require contact with the 
cluster of bees to be effective.  Apistan® was first registered in Nebraska in 1990 and 
reports of resistant mite populations emerged between 1996 and 1997 (Creger 2007). 
Fluvalinate resistance has been widely reported in the United States (Eischen 1995, 1998, 
Elzen et al. 1998, 1999, Macedo et al. 2002a,) and Europe (Milani 1994, Lodesani et al. 
1995, Thompson et al. 2002).  Today, many beekeepers have discontinued the use of 
Apistan® because its effectiveness has significantly decreased.   
The prevalence of fluvalinate-resistant Varroa mite populations in the late 1990’s 
led many U.S. beekeepers to begin using CheckMite+®, an organophosphate acaricide, 
as an alternative mite control agent.  Like Apistan®, CheckMite+® is sold as plastic 
strips impregnated with a miticide (coumaphos) that are placed in the brood chamber for 
6 weeks.  Efficacy of 97-99% has been documented (10% coumaphos strips) (Milani and 
Iob 1998).  CheckMite+® was first registered in Nebraska in 1999 and reports of 
resistant mite populations emerged between 2002 and 2003 (Creger 2007).  By 2002, 
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several instances of coumaphos resistance were reported in the United States (Elzen and 
Westervelt 2002, Pettis 2004).   
Mite-Away II® is a ready-to-use, single application formic acid pad that is 
effective at controlling both Acarapis woodi (tracheal mites) and Varroa mites.  The pad 
is made from wooden fibers and contains 292 grams of 65% formic acid.  The treatment 
period is 21 days and the outside daytime temperature should be between 50 and 79°F.  
Significant adult bee and brood mortality may occur if the daytime temperature exceeds 
82°F during the treatment period.  Several other formulations of formic acid have been 
shown to be effective but are not registered or available to beekeepers.  Calderone (2000) 
was able to achieve 94% efficacy when treating colonies with 300 mL of 65% formic 
acid in a slow release evaporator, but effective and reliable control has proven elusive.  
Liquid formic acid can also be used to reduce Varroa populations. 
Apicure® is formic acid in a gel-like base that slowly releases the active 
ingredient.  Apicure® is sealed in plastic bags that are sliced open and placed in the hive 
for 3 weeks.  Apicure® has limited use due to problems with packaging that prevent mail 
services from accepting it for shipment.  For this reason, Mite-Away II® is the preferred 
Varroa product for those wishing to use formic acid. 
Apiguard® is thymol in a slow-release gel matrix.  Thymol is a naturally 
occurring substance derived from various species of thyme plants (genus Thymus).  
Thymol has proven efficacy against Varroa mites, tracheal mites, and chalkbrood.  
Apiguard® can be purchased in ready-to-use aluminum trays containing 50 g of thymol 
or purchased in 1 or 3 kg tubs.  Fifty grams of Apiguard® is placed on top bars of the 
4  
brood chamber and a second 50 g treatment is applied after the first treatment has 
evaporated (2-4 weeks).  The total treatment period is 4-6 weeks.   
ApiLife-Var® is composed of a vermiculite tablet (5 x 9 x 1 cm) impregnated 
with a 20 gram mixture of thymol (76%), eucalyptol (16.4%), menthol (3.8%), and 
camphor (3.8%). Three tablets are placed on the top bars of brood combs and are left in 
place for 4-8 weeks.  Imdorf et al. (1995) reported that 95% mite mortality was achieved 
if temperatures were optimal (between 15 and 21°C).  ApiLife-Var® is most consistently 
effective when applied to hives that are contained in a single brood chamber.  In contrast, 
its efficacy is less consistent when treating multiple story colonies.  Imdorf et al. (1994, 
1995) found that mite mortality varied considerably when treating multiple story 
colonies.   
Sucrocide® is 40% sucrose octanoate.  The label recommends spraying the bees 
clustered on each frame at 7-10 day intervals.  Three treatments are recommended.  Few 
data indicating the efficacy of Sucrocide® are available.  However, Sheppard et al. 
(2003) reported that following a single treatment with sucrose octanoate esters (solution 
of 0.3% active ingredient in water; 1.5 ounces per frame), mite mortality ranged from 
38% to 87%.      
Hivastan® is a contact miticide that contains 0.3% fenpyroximate.  The product is 
a thick, pliable formulation that can be formed into patties.  The label recommends 
applying a 225 g patty of Hivastan® on the top of the brood frames on paper, wax paper, 
or cardboard.  Two 225 g treatments per year per colony are permitted.  Adult bees 
consume the patties, and in the process, get the material on their bodies and transfer it to 
other bees in the colony by physical contact.  In typical circumstances, the initial 225 g 
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application will be consumed or removed in 6 weeks.  The Hivastan® label precautions 
that a slightly higher incidence of adult bee mortality can occur during the initial 48-72 
hours of the treatment period compared with untreated colonies. 
Chemical resistance, the variable efficacies of current Varroa treatments, the 
adverse effects of treatments on bees, and the risk of hive and hive product contamination 
create a need for alternative treatment methods.  Oxalic acid (OA) is extensively used for 
controlling V. destructor in Europe and Canada due to its high efficacy (>90%) and low 
risk of hive contamination (Charrière & Imdorf 2002, Special Supplement 2005).  Its 
registration is pending in the United States.  OA is applied to colonies by spraying or 
trickling a solution of OA in a 1:1 sugar water solution over the bees (Charrière & Imdorf 
2002) or by sublimating crystals with heat.  When spraying or trickling OA in Canada, 
the recommended application per hive is 50 mL of a solution containing 35 g OA 
dihydrate in one L of 1:1 sugar:water (w:v).  When spraying or trickling OA, the 
maximum dose is 50 mL per hive, whether the bees are in nucs, single, or multiple brood 
chambers.  When evaporating OA in Canada (vaporizer method), the recommended 
application is 1 g OA dihydrate per hive body (Langstroth hive body, 24.4 cm depth) 
(Special Supplement 2005).  Although OA provides effective control of V. destructor, its 
mode of action is unknown.  Further, only one study has quantified the contact toxicity of 
OA to V. destructor (Milani 2001), and the contact toxicity of OA to honey bees has not 
been determined.  In short, OA is extensively used without knowing the basic 
toxicological properties of the compound to V. destructor or A. mellifera. 
There are many important research opportunities surrounding OA.  My 
dissertation research focuses on evaluating OA for reducing Varroa mite populations in 
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honey bee colonies and package bees, determining factors that influence efficacy, and 
investigating the mode of distribution of OA.  The results from my research have 
important implications for the development and implementation of effective management 
strategies for controlling Varroa mites.  Specifically, objectives for my work are: 
1. To evaluate strategies for reducing Varroa mite populations using OA in 
both broodless and brood rearing colonies.   
2. To quantify the contact toxicity of OA to Varroa mites and their honey bee 
host in laboratory bioassays.   
3. To investigate factors that contribute to the distribution of OA in a hive. 
4. To develop a protocol for using OA to reduce Varroa mite populations in 
package bees.   
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Literature Review 
 
History of Varroa in the United States 
 Varroa destructor was first found in the United States in 1987 in Wisconsin 
(Anonymous 1987).  Since their introduction, Varroa mites have spread rapidly across 
the United States.  Varroa are spread locally by drifting of infested adult worker and 
drone adult bees, by the movement of swarms, and by bees robbing weakened colonies 
(De Jong 1990).  Movement of infested colonies for wintering and crop pollination and 
the shipment of package bees and queens are probably responsible for the rapid dispersal 
of Varroa in the United States (de Guzman 1993).  Varroa has greatly reduced 
populations of feral bee colonies in many parts of the United States (Kraus and Page 
1995, Harbo and Hoopingarner 1997).  Substantial losses of managed honey bee colonies 
have also been attributed to Varroa injury (Beetsma 1994, Sammataro 1997, Martin 
2001, Sanford 2001). 
 The number of honey bee colonies in the United States has declined steadily since 
1947.  In 1947, the number of colonies peaked at 5.9 million (Hoff and Willett 1994).  By 
2006, the number of colonies had dwindled to 2.4 million (USDA 2007).  Some of the 
decline may be attributed to urban growth and a reduction in forage plants due to 
monocultural farming practices and herbicides (NASS 1993).  Recently, price 
competition from imports and the deleterious effects from the spread of both tracheal 
mites (Acarapis woodi) and Varroa mites have accelerated the drop in the number of 
managed colonies (NASS 1993).  Varroa is considered the most severe threat to 
beekeeping worldwide (De Jong 1990, Beetsma 1994).       
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Lately, colony collapse disorder (CCD) has afflicted an estimated 23% of 
beekeeping operations across the United States (Cox-Foster et al. 2007).  CCD has 
resulted in a loss of 50 to 90% of colonies in affected beekeeping operations over the 
winter of 2006-2007 (Cox-Foster et al. 2007).  CCD is characterized by the inexplicable 
loss of a colony’s adult bee population and few or no dead bees in or around the hive.  
The later stages of CCD are typified by colonies that have 5 or more frames of brood, 
honey reserves and a queen, but that lack sufficient adult bees to cover and care for the 
brood.  The few bees that remain are frequently newly emerged bees.  Although the cause 
of CCD has not been definitively proven, a team of scientists led by Diana Cox-Foster 
have found that Israeli acute paralysis virus of bees (IAPV) is strongly correlated with 
CCD (Cox-Foster et al. 2007).  While the Cox-Foster et al. (2007) paper presents 
convincing evidence that CCD is related to the presence of IAPV, many questions about 
CCD remain unanswered.  It is unknown whether IAPV acts alone or in concert with 
other factors such as Varroa mites, poor nutrition, exposure to pesticides, and climate.  
Other viruses associated with Varroa infestation include acute paralysis virus, Kashmir 
bee virus, and deformed wing virus (Sammataro 1997).  Their contribution to the CCD 
problem and interaction with IAPV are under investigation (Cox-Foster et al. 2007).   
 
Varroa biology 
 Adult female V. destructor are large (1.1 X 1.6 mm), reddish brown, dorsal-
ventrally flattened external parasites of all castes of honey bees (De Jong 1990, Fries 
1993).  Adult female Varroa are phoretic on adult bees and are found principally on the 
underside of the abdomen between the overlapping abdominal sternites.  Varroa feed on 
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haemolymph by piercing the intersegmental membranes with their chelicerae (De Jong 
1990).  Varroa only leave adult bees to enter brood cells where they reproduce and mate.  
Mites invade worker and drone cells 15-20 hours and 40-50 hours preceding cell capping, 
respectively (Boot et al. 1992).  Drone larvae are preferred over workers, and drone 
brood is often 8-10 times more infested than worker brood (Fuchs 1990).   
 To begin its reproductive phase, an adult female mite must be carried to a suitable 
brood cell by a bee.  The mite then transfers from the adult bee to the rim of the cell and 
quickly moves inside quickly (Boot et al. 1994).  After entering the cell, the mite 
immediately buries itself underneath the bee larva and enters the larval food.  At this 
time, the mite assumes a characteristic position with its posterior ventral plates facing the 
opening of the cell.  The anterior dorsum, mouthparts, anterior ventral plates, and the 
bases of its legs are submerged in the larval food.  The peritremes protrude out of the 
semi-liquid food, perpendicular to its surface (De Jong 1984).  The mite remains in this 
position up to 4 hours after cell capping or until the larval food is consumed.  Once 
liberated from the brood food by the feeding larva, the mite commences feeding on larval 
haemolymph (De Jong 1984). 
 Approximately 60 hours after the cell is capped, the female mite lays a single, 
male egg.  Subsequent female eggs are laid at intervals of 30 hours.  Female mites can lay 
a maximum of 6 female eggs in a drone cell and 5 female eggs in a worker cell (Ifantidis 
1983).  The immature mites develop inside the egg.  At this time, a 6-legged larva is 
visible within.  Approximately 1.5 days after the deposition of a female egg, an 8-legged 
protonymph hatches.  This stage lasts about 3 days, allowing the female mite to feed, 
grow, and then molt to an 8-legged deutonymph.  The deutonymphal stage (similar in 
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size and shape to the adult female) also lasts about 3 days.  Both protonymphal and 
deutonymphal stages are subdivided into a mobile and immobile stage.  About 7.5-8 days 
after the egg is laid, the female deutonymph molts into an adult (Ifantidis 1983, De Jong 
1984, 1990).   
 The male mite develops from egg to adult in 5.5-6 days and is smaller, paler, and 
less sclereotized than the female.  The adult male’s chelicerae (mouthparts used for 
piercing the bee’s integument by the female) are modified for sperm transfer, rendering it 
unable to feed.  Mating takes place within the cell, and adult female mites leave with the 
emerging adult bees.  The males and immature females that are present when the adult 
bee emerges perish (Ifantidis 1983, De Jong 1984, 1990).  Studies of egg chromosome 
number have revealed that the first egg laid normally develops into a male and the 
subsequent eggs into females (Rehm and Ritter 1989).  Varroa have a haplodiploid 
system of sex determination (arrhenotoky).  Males arise from unfertilized eggs and have 
7 chromosomes.  In contrast, females arise from fertilized eggs and have 14 
chromosomes (Ruijter and Pappas 1983).   
 There is a strong preference for mite reproduction in drone brood when both 
worker and drone brood are available (Boot et al. 1992, De Jong 1984, Fuchs 1990).  The 
mechanisms governing this preference are not completely understood and are frequently 
debated.  Le Conte et al. (1989) suggest that chemical stimuli may be important, as 
simple aliphatic esters isolated from drones attract mites.  Boot et al. (1992) propose that 
the larger number of mites found in drone cells may be partly due to the longer period of 
mite invasion into drone brood.  Physical differences between drone and worker cells 
may also influence mite distribution in brood cells.  De Jong and Morse (1988) found that 
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raised cells (drone cells) are more attractive to mites than normal worker cells.  Finally, 
drone brood is capped about 2 days longer than worker brood.  The adaptive advantage of 
reproducing in drone brood is clear considering a greater number of mites are able reach 
sexual maturity and mate due to the longer developmental period (21 days for workers 
and 24 days for drones).   
 An important aspect of Varroa biology is disease transmission.  Varroa destructor 
feeds on the haemolymph of larvae, prepupae, pupae, and adult honey bees.  The 
female’s piercing chelicerae effectively function as “dirty syringes,” exposing its host to 
many pathogens, including viral, bacterial, microsporidial, and fungal diseases (Ball 
1994).  Adult bee symptoms of Varroa infestation include a reduction in population, 
deformed wings, bees crawling away from the hive that are unable to fly, and queen 
supercedure.  Brood symptoms include a spotty brood pattern and brood that appear 
discolored and abnormally positioned.  Symptoms may resemble European foulbrood, 
American foulbrood, or sacbrood disease (Hung et al. 1995).  Shimanuki et al. (1994) 
proposed the name “parasitic mite syndrome” (PMS) for these symptoms.  Several 
viruses may be associated with PMS, but their role in PMS has not been established.  The 
most commonly observed viruses associated with Varroa infestation include sacbrood 
virus (SBV), acute bee paralysis virus (ABPV), chronic bee paralysis virus (CBPV), 
Kashmir bee virus (KBV), deformed wing virus (DWV), black queen cell virus (BQCV), 
and Israeli acute paralysis virus (IAPV) (Sammataro 1997, Cox-Foster et al. 2007).  
There is evidence that Varroa do not cause honey bee colonies to expire solely from 
feeding.  They also act indirectly by activating viruses and providing a port of entry for 
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bacterial and fungal diseases.  Diseases may play a role that is equal or greater than mite 
feeding injury in colony death (Hung et al. 1995). 
 
Varroa on Apis cerana vs. Apis mellifera 
 Varroa jacobsoni was first described by Oudemans in 1904 as a natural 
ectoparasitic mite of the Eastern honey bee Apis cerana F.  Peng et al. (1987) discovered 
that A. cerana has evolved both physiological and behavioral adaptations to V. jacobsoni 
parasitism.  Apis cerana worker bees are able to detect Varroa as they respond 
immediately to mite introduction.  The presence of Varroa triggers a series of behavioral 
responses including auto-grooming, dancing to solicit nest mate grooming, nest mate 
cleaning, and group cleaning.  Eventually, these behaviors lead to the removal of many 
mites from the adult bees and brood (Peng et al. 1987, Harris 2007).  
Recently, Anderson and Trueman (2000) reported that V. jacobsoni is a complex 
of 2 different species that parasitize A. cerana.  The original species, V. jacobsoni, 
encompasses 9 haplotypes that infest A. cerana in the Malaysia-Indonesia region.  In 
contrast, the newly described species, Varroa destructor, includes 6 haplotypes that infest 
A. cerana on mainland Asia.  Movement of A. mellifera by humans into areas where A. 
cerana is endemic in the 1950’s enabled V. destructor to transfer to A. mellifera, a far 
less resistant host (De Jong et al. 1982).  De Jong et al. (1982) reported that colonies 
parasitized by Varroa began dying in autumn of the first year of infestation.  Frequently, 
all colonies in an apiary died in 3-5 years.  Peng et al. (1987) discovered that grooming 
behavior occurs less frequently in Varroa-infested A. mellifera colonies, and that few 
mites are removed by grooming.  Additionally, A. mellifera brood has a longer 
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developmental period (21 days for workers and 24 days for drones) than A. cerana, 
allowing Varroa to reproduce in both worker and drone brood.  In contrast, Varroa mites 
parasitizing A. cerana reproduce almost exclusively in drone brood (developmental time 
of 22 days) because the developmental time of A. cerana worker brood (18 days) is 
insufficient for mite reproduction (Boot et al. 1997).   
 Adult female Varroa mites from different honey bee species show high 
phenotypic consistency, except for body size.  Female mites infesting A. cerana are 
generally smaller than those infesting A. mellifera.  Delfinado-Baker (1988) reported that 
the behavioral, physical, and physiological differences exhibited by Varroa on A. cerana 
and A. mellifera suggest that V. jacobsoni may be more than one species.  Twelve years 
later, Anderson and Trueman (2000) were able to clearly demonstrate (through a 
comprehensive comparative study based on molecular techniques) that V. jacobsoni is 
actually 2 species: V. destructor and V. jacobsoni.  It is now clear that both V. jacobsoni 
and V. destructor parasitize A. cerana, and that only V. destructor parasitizes A. 
mellifera. 
 
Detection methods and treatment thresholds 
 It is essential to assess the degree of V. destructor infestation in honey bee 
colonies to prevent colony injury or loss.  Accurate estimation of mite population allows 
beekeepers to employ control measures when warranted and to save time and money 
when treatment can be delayed (Macedo and Ellis 2000).  Commonly used detection 
methods for Varroa include ether roll, sugar roll, alcohol wash, brood examination, sticky 
boards placed on the bottom board, and acaricides with sticky boards.  Detailed 
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descriptions of these methods can be found in USDA Agricultural Handbook Number 
690, Diagnosis of Honey Bee Diseases (Shimanuki and Knox 2000).    
 Regardless of the detection method employed, assessing the degree of Varroa 
infestation is crucial in determining if control measures are warranted.  In the Midwest, 
colonies with more than 0.12 mites-per-bee when brood is not present (in the fall) will 
have increased winter mortality if mite populations are not reduced.  Colonies with more 
than 0.25 mites-per-bee will almost always perish in the winter (Ali and Ellis 2000).  
When brood is present in mid-August, 0.03 or more mites-per-bee indicates that the 
beekeeper should implement treatment measures as soon as possible.  This may require 
sacrificing honey production to conserve the colonies (Macedo and Ellis 2001).  
Although the above treatment thresholds are a good indicator for Varroa treatment in the 
Midwest, Delaplane (1998) noted that treatment thresholds can vary regionally.  
Delaplane and Hood (1997) suggested that late-season acaricide treatments in first-year 
colonies in the southeastern United States are justified when 300-bee ether roll levels are 
15.1 ± 1.4 mites.  Variation in the duration of the brood rearing period affects mite 
population dynamics, and may explain why treatment thresholds have not been 
established for most of the United States (Delaplane and Hood 1997).  The lack of 
treatment thresholds for all regions and the time required to determine Varroa infestation 
result in many beekeepers applying annual or semi-annual prophylactic miticide 
treatments (Strange and Sheppard 2001).   
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Varroa control 
 
Chemical control 
 Currently, 6 general use (Section 3) chemical treatments are used to control V. 
destructor in the United States: Apistan® (fluvalinate), Apicure® (formic acid), Mite-
Away II® (formic acid), Sucrocide® (sucrose octanoate), Apiguard® (thymol), and 
ApiLife-Var® (76% thymol, 16.4% eucalyptol, 3.8% menthol, and 3.8% camphor).  The 
first product registered for Varroa control in the United States was Apistan®.  It achieved 
nearly 100% efficacy in susceptible mite populations (Faucon et al. 1995).  Fluvalinate’s 
target is the axonal transmission of nerve impulses.  It alters the permeability of sodium 
channels and causes prolonged depolarization of nerve membranes.  Apistan® was 
initially approved in 1990 as a Section 3 general use chemical, and its Section 3 
registration remains active in the United States (U.S. EPA 2007a).  However, the active 
ingredient, tau fluvalinate, was available to beekeepers under a Section 18 registration 
from 1987-1989.  Liquid formulations of fluvalinate were applied to wooden strips that 
were placed in the brood chamber (Ellis et al. 1988).  Currently, Apistan® is sold as 
impregnated plastic strips that are placed in the brood chamber for 6-8 weeks and act as a 
contact pesticide.  Fluvalinate resistance has been documented in the United States 
(Eischen 1995, 1998, Elzen et al. 1998, 1999, Macedo et al. 2002a,) and Europe (Milani 
1994, Lodesani et al. 1995, Thompson et al. 2002).  Efficacy has been reported to drop to 
10-70% in mite populations that have developed resistance (Pettis et al. 1998, Macedo et 
al. 2002a).  Today, many U.S. beekeepers have discontinued the use of Apistan® due to 
loss of efficacy.   
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Apicure® is 65% formic acid in a gel-like base that slowly releases the active 
ingredient.  Apicure® is sealed in plastic bags that are sliced open and placed in hives for 
3 weeks.  Formic acid is a fumigant that kills Varroa by respiratory inhibition (Imdorf et 
al. 1999.  Since fumigant volatilization is temperature dependent, the results of treatment 
often exhibit variable results.  Queen loss and brood damage are common side effects of 
overexposure to formic acid.  Several other formulations of formic acid have been shown 
to be effective but are not registered or available to beekeepers.  Calderone (2000) was 
able to achieve 94% efficacy when treating colonies with 300 mL of 65% formic acid in a 
slow release evaporator, but effective and reliable control has proven elusive.  Although 
registered (Section 3), Apicure® is not available to most beekeepers due to packaging 
problems and the refusal of mail services to accept the current packaging for shipment.  
To date, Apicure® has not been widely distributed or applied.  Mite-Away II® is the only 
formic acid based miticide currently available to U.S. beekeepers. 
Mite-Away II® has a Section 3 registration that was approved on March 31, 2005 
(U.S. EPA 2005).  Mite-Away II™ is a ready-to-use, single application formic acid pad 
that is effective at controlling both tracheal and Varroa mites (Mite-Away II® U.S. 
label).  The pad is made from wooden fibers and contains 292 grams of 65% formic acid.  
A 3.8 cm spacer rim must be placed over the brood chamber to accommodate the Mite-
Away II® pad.  The pad is placed in the hive directly over the brood chamber.  The 
treatment period is 21 days and the outside daytime temperature should be between 50 
and 79°F.  The label recommends that applicators remove the pads from hives in the 
event of a heat wave (>82°F) within the first 7 days of treatment.  Significant adult bee 
mortality, brood mortality, and absconding may occur if the daytime temperature exceeds 
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82°F during the treatment period.  Like Apicure®, the formic acid present in Mite-Away 
II® acts as a fumigant and kills Varroa by respiratory inhibition (Imdorf et al. 1999), 
rendering its effectiveness highly variable.  Formic acid is also hazardous to applicators 
and the EPA mandates stringent precautionary labeling for Mite-Away II®.  
Sucrocide® (40% sucrose octanoate) is a general use Varroa treatment and is 
classified as a biopesticide by the EPA.  Sucrose octanoate is a mixture of sugar esters 
that are manufactured from sucrose (table sugar) and an octanoic acid ester that is 
commonly found in plants and animals.  The label recommends spraying both sides of 
each frame at 7-10 day intervals.  Three treatments are recommended.  The surfactant 
effect of sucrose octanoate esters de-waxes the cuticle of Varroa, causing desiccation 
(U.S. EPA. 2006a).  No harmful effects to bees, humans, or the environment are expected 
from the use of Sucrocide® (U.S. EPA 2006a).  Few data indicating the efficacy of 
Sucrocide® are available.  However, Sheppard et al. (2003) reported that following a 
single treatment with sucrose octanoate esters (solution of 0.3% active ingredient in 
water; 1.5 ounces per frame), mite mortality ranged from 38% to 87%.  Currently, 
Sucrocide® is available in all states and has a Section 3 registration (U.S. EPA 2006a).   
Apiguard® received EPA approval for use in the United States in January 2006.  
Prior to United States approval, Apiguard® was only available in European countries.  
Currently, Apiguard® has a Section 3 registration in the United States (U.S. EPA 2006b).  
Apiguard® is thymol in a slow-release gel matrix.  Thymol is a naturally occurring 
substance derived from various species of thyme plants (genus Thymus).  Thymol has 
proven efficacy against Varroa mites, tracheal mites, and chalkbrood (Apiguard® U.S. 
label).  Apiguard® can be purchased in ready-to-use aluminum trays containing 50 g of 
18  
thymol in a gel matrix or purchased in 1 kg or 3 kg tubs for beekeepers with many 
colonies to treat.  The gel is placed in the hive using the dosing tools (scoop and spatula) 
that are supplied with the 1 kg and 3 kg tubs.  The first dose requires the applicator to 
measure 50 g of the gel using the scoop and spatula.  To do so, the applicator must 
completely fill the scoop with gel and then level the excess with the spatula.  The gel is 
then spread to an even thickness on a waxy cardboard tray (supplied) and placed centrally 
on top of the brood frames.  After 2 weeks, a second 50 g dose is applied using the 
methods described above.  Apiguard® is left in the colony until it disappears completely 
from the tray or until supers are installed.  Generally, the total treatment period lasts 4-6 
weeks.   
Registration was initially approved for ApiLife-Var® in 2003 under an EPA 
Section 18 Emergency Exemption for states requesting approval due to Apistan® and 
CheckMite+® resistance.  Currently, ApiLife-Var® has a Section 3 registration in the 
United States.  ApiLife-Var® is composed of a vermiculite tablet (5 x 9 x 1 cm) 
impregnated with a 20 gram mixture of thymol (76%), eucalyptol (16.4%), menthol 
(3.8%), and camphor (3.8%). The active ingredient, thymol, is a fumigant that 
effectively kills Varroa mites, but its mode of action is unknown.  The tablets are placed 
on the top bars of brood combs and are left in place for 4-8 weeks.  Imdorf et al. (1995) 
reported that 95% mite mortality was achieved if temperatures were optimal (between 15 
and 21°C).  ApiLife-Var® residues in hive products are not considered a health risk.  The 
applicator should not get ApiLife-Var® on their hand and should not touch their eyes 
while treating.  ApiLife-Var® is most consistently effective when applied to hives that 
are contained in a single brood chamber.  In contrast, its efficacy is less consistent when 
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treating multiple story colonies.  Imdorf et al. (1994, 1995) found that mite mortality 
varied considerably when treating multiple story colonies.   
Two restricted use products are available for Varroa control in the United States, 
CheckMite+® (coumaphos) and Hivastan® (fenpyroximate).  Registration was initially 
approved for CheckMite+® in 1998 under an EPA Section 18 Emergency Exemption for 
states requesting approval due to Apistan® resistance.  The EPA has continued to renew 
the exemption and has made CheckMite+® available in a number of states on a year-to-
year basis.  The active ingredient, coumaphos, is an organophosphate and acts as an 
acetylcholinesterase inhibitor.  This mode of action makes the use of coumaphos 
hazardous to applicators.  Treatments must be applied at a time when bees are not 
producing a surplus honey crop.  CheckMite+® is sold as plastic strips impregnated with 
miticide that are placed in the brood chamber for 6 weeks.  Efficacy of 97-99% has been 
documented (10% coumaphos strips) (Milani and Iob 1998).  There are also concerns 
about the risk of contaminating hive products, and a 4 week withdrawal period is required 
before adding surplus honey supers.  Chemical resistant gloves must be worn when 
handling the strips.  Coumaphos is highly lipophilic and residues are most likely to be 
found in beeswax.  Coumaphos resistance has been reported in the United States (Elzen 
and Westervelt 2002, Pettis 2004) and Italy (Lodesani 1996).  
Registration was approved for Hivastan® (fenpyroximate) in May 2007 under an 
EPA Section 18 Emergency Exemption (U.S. EPA 2007b).  Fenpyroximate is a synthetic 
acaricide that inhibits the mitochondrial electron transport of complex I (NADH 
dehydrogenase) (Nauen and  Bretschneider 2002).  Hivastan® is a contact miticide that 
contains 0.3% fenpyroximate.  The product is a thick, pliable formulation that can be 
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formed into patties.  The label recommends applying a 225 g patty of Hivastan® on top 
of the brood frames on paper, wax paper, or cardboard.  Two 225 g treatments per year 
per colony are permitted.  Adult bees consume the patties, and in the process, get the 
material on their bodies and transfer it to other bees in the colony by physical contact 
(Hivastan® U.S. label).  In typical circumstances, the initial 225 g application will be 
consumed or removed in 6 weeks.  The Hivastan® label precautions that a slightly higher 
incidence of adult bee mortality can occur during the initial 48-72 hours of the treatment 
period compared with untreated colonies. 
 
Biotechnical control 
 Chemical resistance, the variable efficacies of current Varroa treatments, the 
adverse effects of treatments on bees, and the risk of hive and hive product contamination 
create a need for alternative treatment methods.  Lindberg et al. (2000) and Ali et al. 
(2002) recently evaluated several essential oils and related compounds including clove 
oil, benzyl acetate, thymol, carvacrol, methyl salicylate, and perillyl acetate as treatments 
for Varroa.  The results indicated that the compounds they tested may not be highly 
effective under all conditions, but suggest that they could be a useful component of an 
integrated pest management approach.  Charrière and Imdorf (2002) evaluated oxalic and 
lactic acids in Europe as an alternative Varroa treatment.  Their results indicate that 
oxalic acid is effective in broodless colonies, but their protocol requires applying the 
material to the bees on each frame, and bees were harmed if overdosed.  Oxalic and lactic 
acids can be applied by spraying or trickling on adult bees or by sublimation of the acid 
crystals in the hive.   
21  
Heat treatment (Tabor and Ambrose 2001), powdered sugar dusting (Aliano and 
Ellis 2005a, Fakhimzadeh 2000), pollen traps (Cakmak et al. 2002), and even electrical 
“zapping” (Huang 2001) have also been evaluated as Varroa treatment methods.  Like 
other alternative Varroa treatments, the above methods exhibit potential as part of an 
integrated pest management strategy, but they are labor intensive and often less effective 
than other registered Varroa control products.  If labor costs are considered, the 
treatments described above are more expensive than the alternatives.   
One of the first products used to control Varroa was Sineacar, a mixture of 
powdered sugar (98.2%) and chloropropylate and bromopropylate (1.8%) (Ramirez 
1994).  The “clogging” of the ambulacrum with dust may explain why Sineacar knocked 
mites off adult honey bees without killing them first.  The ambulacrum of adult female 
Varroa is a pretarsus with protractile, claw-like sclerites used for grasping the hairs of 
bees (Ramirez and Malavasi 1991).  The claw-like sclerites of the ambulacrum enable 
mites to move rapidly on adult bees and other substrata.  Macedo et al. (2002b) were able 
to achieve 92.9 ± 5.5% Varroa mite recovery by isolating bees from their nest and 
dusting them with powdered sugar.  Similarly, Shah and Shah (1988) reported that a fine 
powder of wheat flour was effective at knocking Varroa off adult honey bees, but they 
did not indicate the percentage mite fall.  In addition to dust adhering to the tarsal pads of 
Varroa, Macedo and Ellis (2001) suggest 2 more factors that may contribute to mite fall 
when bees are dusted with powdered sugar.  They observed that dust stimulates the bees’ 
grooming behavior and they proposed that it would result in greater mite removal.  They 
also proposed that dust on the mite’s body may stimulate it to release from its host to 
groom itself.   
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 Fakhimzadeh (2000) evaluated powdered sugar as a tool for Varroa control.  
Fakhimzadeh applied sugar directly to adult bees in their nest and counted daily mite fall 
following treatment.  He found post-treatment daily mite fall was significantly higher 
than pre-treatment daily mite fall.  However, he did not determine the percentage of mites 
that were removed from the hives.  Fakhimzadeh concluded that powdered sugar is useful 
in reducing mite infestation in a colony, but he indicates that his method still needs 
refining.  In a related study, Fakhimzadeh (2001b) investigated the effects of powdered 
sugar on honey bee colony development.  He applied sugar to the colony (10-20g) at 3-, 
7-, and 14-day intervals.  He observed that sugar particles did not enter the bee’s spiracles 
or tracheal ducts.  Also, the treatment had no obvious side effects on capped brood or the 
growth of the bee population.  Additionally, Fakhimzadeh found that powdered sugar 
treatment did not cause queen loss or queen supercedure, even if the treatment was 
applied as frequently as every 3 days for one month.   
Aliano and Ellis (2005a) developed a powdered sugar dusting technique that 
requires isolating a colony’s adult bee population in a detachable box prior to powdered 
sugar application.  By applying a bee repellent to a colony, Aliano and Ellis (2005a) 
forced adult bees into a detachable ‘bee box’ where the adult bee population was dusted 
with powdered sugar.  Adult honey bee populations treated in this manner dropped 76.7 ± 
3.6% of their mites.  One drawback of the Aliano and Ellis (2005a) technique is that it is 
labor intensive and time consuming.  Part-time beekeepers are more likely to adopt this 
technique than full-time beekeepers, especially those trying to reduce the use of chemical 
treatments.  Aliano and Ellis (2005b) performed a follow up study to test the effects of 
powdered sugar entering brood cells when powdered sugar is applied to a hive.  Their 
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results indicate that only large amounts (0.6 g per 152 cells) of powdered sugar applied 
directly to brood cells harms immature honey bees.  Further, Aliano and Ellis (2005b) 
indicate that brood removal following management practices that introduce powdered 
sugar into colonies will be restricted to eggs. 
 
Genetic control 
Another approach to Varroa control is bee breeding.  Spivak and Reuter (2001) 
reported that colonies bred for hygienic behavior maintained lower mite loads for up to 
one year without treatment.  Ibrahim and Spivak (2005) showed that bees bred for 
suppression of mite reproduction (SMR) also express hygienic behavior.  Harbo and 
Harris (2001) reported that single drone inseminated queens bred for SMR can 
significantly reduce mite populations.  Recently, Harris (2007) discovered that honey 
bees bred for SMR resist the growth of Varroa mites by removing mite-infested pupae 
from capped brood.  Harris (2007) named this behavior Varroa-sensitive hygiene (VSH) 
and describes VSH as “a multi-step process that involves detection, uncapping of the cell, 
and removal of the host.”   
 Other heritable traits that have been associated with Varroa resistance include the 
duration of the capped period and the proportion of mites in brood cells (Harbo and 
Harris 1999).  A disadvantage of intense selection for one trait is that selection for other 
valuable traits (honey production, gentleness, swarming, etc) may be reduced.  
Furthermore, intense selection for a single trait may narrow the genetic base over time.  
Finally, specific traits such as hygienic behavior and suppression of mite reproduction 
may be lost when a colony swarms or supercedes its queen.  Resistant stock would lower 
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operating costs, reduce selection pressure for mite resistance to chemical treatments, and 
reduce the risks of chemical residues in honey and hive products.  Varroa resistant lines 
probably will not eliminate the need for chemical treatments, but they may help 
beekeepers reduce the frequency of treatments and the selective pressures that promote 
miticide resistance (Ellis 2001).      
 
Oxalic acid 
Oxalic acid (OA) is a dicarboxylic acid and is approximately 10,000 times 
stronger than acetic acid.  Oxalic acid is available in two formulations: anhydrous 
(C2H2O4) (CAS # 144-62-7) and dihydrate (C2H2O4 2H2O) (CAS # 6153-56-6).  Oxalic 
acid is commonly utilized in the industrial sector as a wood bleaching agent, as a mordant 
in dyeing processes, and as a surface pretreatment for stainless steels prior to applying a 
corrosion-inhibiting coating.  Oxalic acid is also employed in the domestic sector as a 
household cleaner and rust remover.  A structural sketch of anhydrous OA (C2H2O4) is 
included below.   
   
Oxalic acid is a common chemical in plants, but its physiological role is not 
completely understood.  Scientists suggest that OA is involved in storage and regulation 
of calcium, seed germination, detoxification, ion balance, structural integrity, and insect 
repellence (EMEA 2004).  Oxalic acid concentrations in plants range from 5 mg/kg up to 
20,000 mg/kg dry weight (EMEA 2004).  In humans, 30-70% (20-30 mg) of the OA 
excreted daily in urine originates from endogenous sources.  The daily intake of OA in 
O 
C HO OH 
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the European diet averages 50 mg per day and is excreted in fecal material (Libert and 
Franceschi 1987, EMEA 2004).  Dietary intake of OA varies widely based on the types 
of food eaten.  Although most humans safely consume and excrete OA on a daily basis, 
excessive consumption of foods with high OA concentrations is a health concern because 
it has been implicated in several clinical disorders including cardiovascular disease and 
renal calculi (Singh et al. 1972).      
The usefulness of OA as a Varroa mite control agent has been known since the 
end of the 20th century (Popov et al. 1989).  The commercial availability and the low risk 
of hive product contamination render OA an attractive chemical for Varroa control.  
Numerous investigations of OA as a Varroa control agent have been conducted in 
European countries (Rademacher and Harz 2006).  The European Agency for the 
Evaluation of Medicinal Products (EMEA) determined the maximum residue limit 
(MRL) for OA in honey to be 50 milliequivalents of free acid in December 2004 
(Rademacher and Imdorf 2004).  In all European countries, government approval is only 
given to a veterinary drug after the EMEA has determined the MRL of the active 
ingredient.  Currently, every European country can apply for the legal approval of OA as 
a drug for honey bee colonies because the EMEA has determined the MRL for OA.  If 
OA is applied properly, there is little risk of harmful residues in honey.      
Oxalic acid is also a legal Varroa treatment in Canada.  In 2005, Health Canada’s 
Pest Management Regulatory Agency (PMRA) made an interim determination that OA 
can be safely applied to honey bee colonies to control Varroa provided that specific 
limitations and precautions are respected (Special supplement 2005).  The Canadian 
Honey Council has provided the American Beekeeping Federation (ABF) their 
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registration data packet to expedite the registration of OA in the United States.  The ABF 
is leading the registration process and is working with the United States Environmental 
Protection Agency to register OA as a biopesticide.  Oxalic acid’s registration is pending 
in the United States.  My studies will contribute to the registration of OA and will guide 
beekeepers in how to apply the product safely and effectively once it is registered in the 
United States.  
A review article by Rademacher and Harz (2006) summarizes over 50 references 
related to the use of OA in European countries.  Their review article covers the efficacy 
of OA against Varroa and honey bee tolerance for the trickling, spraying, and 
evaporating application methods.  The trickle and spray methods of OA application were 
employed in my dissertation research.  I chose to exclude the evaporation method due to 
inherent hazards to the applicator.  When OA sublimates, both OA and formic acid fumes 
are liberated and can permanently damage lung tissues if inhaled.  Furthermore, the 
European literature regarding OA efficacy indicates that the trickle, spray, and 
evaporation methods of application are equally effective against Varroa mites.     
 
Trickling method 
The trickling method for applying OA is simple, quick, inexpensive, and 
effective.  To trickle OA, a solution of OA in sugar water is applied with a syringe 
directly onto adult bees occupying the spaces between the combs.  It takes about 1.5 
minutes to treat a colony and costs 4-5 cents per hive to purchase the OA required.  
Rademacher and Harz’s (2006) review found that most researchers recommend a dose of 
5 mL per bee space (30-50 mL per hive).  Oxalic acid is most effective during autumn or 
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when colonies are broodless and the temperature is above freezing.  Oxalic acid is most 
effective when colonies have little or no brood because OA does not kill mites in sealed 
brood cells (Schuster and Schürzinger 2003). 
Most research reviewed by Nanetti et al. (2003) and Rademacher and Harz (2006) 
found that a single autumn trickle treatment with a 3.0% OA sugar water solution (1:1 by 
weight) provided an efficacy of greater than 90% in Central Europe.  Charrière and 
Imdorf (2002) found that a slightly more concentrated OA solution (3.5%) resulted in 
greater than 95% efficacy.  They also tested the efficacy of a 3.0% OA sugar water 
solution with a lower sugar content (1:2; sugar:water by weight) and concluded that the 
solution with a 1:2 ratio of sugar:water seemed to have a negative influence of efficacy, 
although the difference was not significant.      
Experiments in which OA solutions stronger than 3.5% were applied indicate that 
increasing the OA concentration above 3.5% does not increase efficacy (Charrière and 
Imdorf 2002, Nanetti et al. 2003).  The most concentrated OA solutions examined ranged 
between 6 and 8% and reduced the efficacy when compared to a 3 or 3.5% solution 
(Liebig 1998, Nanetti et al. 2003).  In Central Europe, adult bees tolerated a single 
autumn trickle treatment concentration up to 4.6% OA (Büchler 2002, Charrière and 
Imdorf 2002, Nanetti et al. 2003).  Liebig (1998) quantified the impact on colonies when 
applying OA solutions with concentrations greater than 5% and described significant 
adult bee mortality, poor over-wintering ability, and impaired spring development.   
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Spraying method 
 Like the trickle method, the spray method is most effective when colonies are 
broodless, and it should only be conducted when the temperature is above freezing.  
When implementing the spray method, a solution of OA and sugar water is sprayed onto 
the adult bees on both sides of each comb.  The combs must be individually removed 
from their hive bodies for application and adult bees located on the hive walls and bottom 
board are sprayed as well.  As a result, the spray method requires more time and labor 
than the trickle method. 
Most studies of the spray method were conducted in Central Europe using 
broodless colonies with outside temperatures ranging from 5 to 12.3°C (Rademacher and 
Harz 2006).  A single autumn spray treatment using a 3.0% OA sugar water solution (1:1 
by weight) and doses of 3-4 mL per comb side provided efficacies of 97.3 to 98.8% 
(Charrière et al. 2004, Imdorf et al. 1995).  These doses were tolerated well as none of 
the experimental colonies lost their queen and adult bee mortality was not significantly 
increased.  However, Charrière et al. (2004) reported winter losses of 11 to 26% of adult 
bees.  The adult bee losses were numerically higher than control colonies (12 to 16%), 
however the differences were not significant.      
 
Other aspects of OA for Varroa control 
Although OA provides effective control of Varroa, its mode of action is 
unknown.  Furthermore, only one study has quantified the contact toxicity of OA to 
Varroa (Milani 2001), and the contact toxicity of OA to honey bees has not been 
determined.  Milani (2001) quantified the toxicity of OA to Varroa mites collected from 
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bee brood.  Milani reported that the 24 hour LD50 (95% CL) (median lethal density) for 
Varroa mites collected from brood was 1.9 (1.49 to 2.36) μg/cm2.  One limitation of the 
Milani (2001) study is that it did not quantify the toxicity of OA to phoretic Varroa 
mites, the life cycle stage that is exposed to OA when colonies are treated (Schuster and 
Schürzinger 2003).  Interestingly, OA is extensively used without knowing its basic 
toxicological properties to either Varroa mites or honey bees. 
Recently, Fries (2006) answered an important question regarding OA application 
techniques.  The question was: which factor is critical for efficacy in Varroa control, the 
total amount or the concentration of OA?  Fries (2006) divided 89 honey bee colonies 
into 3 experimental groups: trickle 30 mL sugar water solution, trickle 30 mL 3.2% OA 
sugar water solution, and trickle 60 mL 1.6% OA sugar water solution.  The results 
showed that trickling 30 mL of a 3.2% OA solution is significantly more effective (92.2% 
efficacious) than trickling 60 mL of a 1.6% OA solution (68.3% efficacious).  Fries 
(2006) clearly demonstrated that it is the concentration of OA that is critical for high 
efficacy rather than the total amount of OA applied to a colony.   
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Research objectives 
 
 My overall dissertation objective was to develop techniques for using OA to 
suppress Varroa mites in the North Central Region (NCR) of the United States.  When I 
started my Ph.D. research in 2004, OA treatment had not been tested in the United States 
as a Varroa suppression technique.  Chapter 1 describes how I quantified the acute 
contact toxicity of OA to Varroa mites and their honey bee hosts in laboratory bioassays.  
Chapters 2 and 3 describe how I investigated the efficacy of OA in the NCR of the 
United States.  Chapters 4 and 5 document my development of a protocol for using OA to 
eliminate mites from package bees.  Finally, chapter 6 describes my methodology for 
investigating how OA is distributed in honey bee colonies when applied using the trickle 
method. 
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Chapter 1 
 
Acute contact toxicity of oxalic acid to Varroa destructor 
(Acari: Varroidae) and their Apis mellifera (Hymenoptera: Apidae) hosts in 
laboratory bioassays 
 
Abstract 
  I performed laboratory bioassays to characterize the acute contact toxicity of 
oxalic acid (OA) to Varroa destructor (Anderson & Trueman) and their honey bee hosts 
(Apis mellifera).  Specifically, I conducted glass-vial residual bioassays to determine the 
lethal concentration of OA for Varroa, and I conducted topical applications of OA in 
acetone to determine the lethal dose for honey bees.  The results indicate that OA has a 
low acute toxicity to honey bees and a high acute toxicity to mites.  The toxicity data will 
help guide scientists in delivering optimum dosages of OA to the parasite and its host, 
and will be useful in making treatment recommendations.  The data will also establish a 
baseline for OA susceptibility for both parasite and host to compare with future 
populations if Varroa mites exhibit resistance to OA. 
 
Introduction 
The objective of this study was to characterize the acute contact toxicity of OA to 
Varroa mites and their honey bee hosts in laboratory bioassays.  Only one study has 
quantified the contact toxicity of OA to Varroa mites collected from brood cells (Milani 
2001), and the contact toxicity of OA to honey bees has not been determined.  One 
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limitation of the Milani (2001) study is that it did not quantify the toxicity of OA to 
phoretic Varroa mites.  Oxalic acid does not kill mites in sealed brood cells (Schuster and 
Schürzinger 2003), thus the characterization of the contact toxicity of OA to phoretic 
Varroa mites has not been determined.  Oxalic acid is extensively used without knowing 
the basic toxicological properties of the compound to Varroa mites or honey bees.  The 
results of this research will be useful in formulating treatment recommendations for the 
North Central Region of the United States.  The data will also establish a baseline for OA 
susceptibility for both parasite and host to compare with future populations if Varroa 
mites exhibit resistance to OA. 
 
Materials and Methods 
Collection of V. destructor 
I collected adult worker bees from a single, mite-infested colony of Carniolan 
honey bees located on the University of Nebraska campus in February 2005.  I shook the 
bees from each frame (12 frames total) through a funnel into a bulk bee box.  I then 
subdivided the bees into six smaller wooden boxes that measured 17.75 cm long, 15.25 
cm wide, and 10.15 cm deep (inside diameter).  Each box had an 8-mesh screen on one of 
the 17.75 cm X 15.25 cm sides for ventilation and mite collection.  I attached a pint jar of 
sugar water (1:1 by volume) to each box and stored the boxes at 15.6°C in complete 
darkness until needed for experimentation (no longer than 2 days). 
I harvested mites from adult bees by applying 18 g of powdered sugar through the 
screen of each box (Aliano & Ellis 2005a).  I inverted the boxes after bees were 
thoroughly coated with powdered sugar to collect mites (about 30 s).  The boxes 
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remained inverted until mite fall ceased (about 20 min).  Approximately 100 viable mites 
were recovered per cage.  I gently brushed the powdered sugar off mites with a fine paint 
brush before transferring them to 20 mL glass scintillation vials (Wheaton Scientific, 
Millville, NJ) for OA exposure.  
 
Glass-vial residual bioassays for V. destructor 
I used techniques described by Plapp and Vinson (1977) and Macedo et al. 
(2002a) for conducting glass-vial residual bioassays.  I prepared serial dilutions of oxalic 
acid dihydrate (>99% purity) (The Science Company, Denver, CO) (CAS # 6153-56-6) in 
acetone and conducted a preliminary range-finding bioassay to determine at least 3 
concentrations that provided Varroa mortalities >0 and <100%.  I prepared 7 
concentrations of OA in acetone for the definitive bioassay (1.0, 0.3, 0.1, 0.03, 0.01, 
0.003, and 0.001 mg/mL).  I pipetted one-half mL of each solution into four, 20 mL glass 
scintillation vials for each treatment, including an acetone control.  The 8 resulting OA 
concentrations that I tested in the definitive bioassay were 500, 150, 50, 15, 5, 1.5, 0.5, 
and 0.0 μg OA per vial.  I rolled all vials (32 total) on their sides under a fume hood to 
evaporate the acetone while evenly coating the vials with OA.  I promptly removed the 
vials after the acetone had evaporated (4 to 5 min).  I gently brushed ten mites into each 
vial, screwed the cap on tightly, and placed the vials in a dark incubator for 24 h (26°C 
and 90% relative humidity).  One vial of 10 mites constituted a replication and four vials 
(40 mites) were used for each of the 8 concentrations.  I scored mite mortality 24 h later 
by examining mites under a light microscope.  Mites were considered dead if they did not 
respond to probing with a small paint brush. 
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Topical application of OA to adult bees   
I prepared serial dilutions of oxalic acid dihydrate (>99% purity) (The Science 
Company, Denver, CO) (CAS # 6153-56-6) in acetone and conducted a preliminary 
range-finding bioassay to determine at least 3 doses that provided honey bee mortalities 
>0 and <100%.  Two to 7 day old bees from C.F. Koehnen & Sons Inc. (Glenn, CA) were 
shipped to the University of Nebraska in March 2005 and were used for the range-finding 
bioassay.  I used the results from the range-finding bioassay to establish the definitive 
bioassay dosage levels.  
I conducted the definitive bioassay in September 2005 using 2 to 7 day old bees 
that were obtained from brood frames kept in an incubator.  I placed 10 bees in each of 
32 Benton mailing cages with queen candy.  One cage of 10 worker bees constituted a 
replication and 4 cages (40 bees) were tested for each treatment.  I randomly assigned 
each cage to 1 of the 8 concentrations, and all 10 bees within a cage received the same 
treatment.  I prepared a 200 mg/mL solution of OA in acetone.  I dosed honey bees with 
10.0, 8.0, 4.0, 2.0, 1.0, or 0.5 μL of the 200 mg/mL stock solution.  These doses 
correspond to 2000, 1600, 800, 400, 200, and 100 μg OA per bee, respectively.  I applied 
the doses to individual bee abdomens using a Hamilton microsyringe and repeating 
dispenser (Hamilton Company, Reno, NV) after anesthetizing bees with CO2.  I included 
a 10 μL control (acetone only) in the bioassay along with a dry control in which bees 
were anesthetized with CO2 but were not treated with acetone.  I held the bees at 21.7 ± 
0.4°C and 46.3 ± 1.5% relative humidity in darkness for 72 h except for brief periods 
when water was administered to the cages.  I provided water twice daily to the bees 
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throughout the experiment by brushing the cage screens with several drops of water.  I 
evaluated mortality 24, 48, and 72 h after treatment. 
 
Statistical analysis  
I analyzed the results with Probit analysis (Finney 1971) using the POLO-PC 
statistical software (LeOra Software 1991), and I took into account natural mortality.  
The concentrations that I used for the Probit analysis of the mite bioassay data were 
expressed as μg per vial.   The doses that I used for the Probit analysis of the honey bee 
bioassay data were expressed as μg per bee.      
  
Results 
V. destructor bioassays 
The results for the definitive bioassay are summarized in Table 1.1.  The natural 
mortality for the definitive bioassay was 9.7 ± 3.4% after 24 h. 
 
Honey bee bioassays  
Doses of OA less than 100 μg per bee did not cause significant mortality after 48 
h in the range-finding bioassay.  Further, it was impossible to calculate the 24 and 48 h 
LD50’s for honey bees tested in the range-finding bioassay because significant mortality 
did not occur until at least 72 h post-treatment.  Aliquots of a 200 mg/mL solution of OA 
in acetone were used to dose honey bees in both the range-finding and definitive 
bioassays because solutions greater than 200 mg/mL clogged the microsyringe, making it 
impossible to deliver accurate doses of OA.  The results for the definitive bioassay are 
36  
summarized in Table 1.1.  Only the 10 μL acetone control group was used for Probit 
analysis of the definitive bioassay data because the 10 μL acetone control had slightly 
more mortality than the dry control group.  The natural mortality for the definitive 
bioassay was 4.0 ± 2.5% after 48 h.  I was unable to calculate a confidence interval for 
the 72 h LD50 because all bees in the 2000, 1600, 800, and 400 μg OA per bee treatments 
died after 72 h.  The estimated 72 h LD50 for honey bees was 194.89 μg per bee, based on 
the 100 and 200 μg OA per bee treatments.    
 
Discussion 
 Milani (2001) is the only report that quantifies the toxicity of OA to V. destructor 
collected from bee brood, where the 24 h median lethal density (OA density expected to 
cause 50% mortality) for V. destructor collected from bee pupae with white eyes was 1.9 
μg/cm2 (95% fiducial limits = 1.49 to 2.36).  The mites collected from brood were 
exposed to OA for 4 h by placing them on glass disks that were sprayed with solutions of 
OA.  The mites were then transferred to clean glass Petri dishes at 32.5°C and 75% 
relative humidity.  My results indicate that the 24 h LC50 for phoretic mites is 5.12 μg per 
vial.  By assuming the area of a single, 20 mL scintillation vial treated with OA was 
approximately 20 cm2, the 24 h median lethal density in my study was calculated to be 
0.26 μg/cm2.  One likely reason for the apparent higher toxicity in my study is that Milani 
exposed mites to OA for 4 h versus 24 h in my bioassays.  Further, the previous study 
used mites collected from brood as experimental material, and I collected mites from 
adult bees.  Differences between mites collected from adults versus brood could have also 
affected bioassay results.  However, I believe it is preferable to use phoretic mites for 
37  
conducting OA bioassays because OA does not kill mites in brood when applied to a 
hive.     
 The mode of action for OA is not completely understood.  My results suggest that 
OA may exhibit its lethal effects on mites via contact.  However, I cannot rule out that 
some mite mortality was caused by exposure to OA vapors.  I expect that mite mortality 
resulting from exposure to OA vapors was minimal because OA has a low volatility at 
room temperature (vapor pressure < 0.001 mm Hg at 25°C; melting point of 101-102°C) 
(Merck Index 1996).  Charrière and Imdorf (2002) reported that OA mixed in 1:1 sugar 
water exhibits greater miticidal effectiveness than solutions with half as much sugar (1:2 
sugar water).  Further, Milani (2001) indicates that sucrose and glycerol are synergists of 
OA under laboratory conditions due to sucrose’s ability to cause OA to become more 
hygroscopic.  Perhaps the sugar water solution adheres better to bees, thus increasing 
mite exposure to OA.     
 The 400, 800, 1600, and 2000 μg per bee doses applied in the definitive bioassay 
completely covered the bees’ abdomen with OA crystals.  Further, the 2000 μg per bee 
dose that was delivered in 10 μL of acetone completely soaked the bees with some 
runoff.  My results indicate that it is nearly impossible to kill 100% of a test population of 
adult bees in 24 h by topically applying OA in acetone.  I conclude that OA has a 
relatively low acute toxicity to honey bees.  There are several accounts in the literature of 
increased adult bee mortality as a result of OA application within hives (Charrière and 
Imdorf 2002, Imdorf et al. 1998), suggesting that OA may not exhibit its lethal effect on 
honey bees until more than 24 h after exposure. 
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 A typical honey bee colony in the North Central Region of the United States has a 
November adult bee population of 35,000 bees (personal observation).  According to the 
Canadian protocol (Special Supplement 2005), a beekeeper would apply a maximum of 2 
g OA per hive for Varroa treatment (trickle or vaporizer methods).  The resulting dose of 
OA per bee would have a maximum value of 57.1 μg per bee (2,000,000 μg OA / 35,000 
bees).  Results from acute exposure bioassays suggests that 57.1 μg per bee is 
considerably below the 48 h LD10 (176.68 μg per bee).  My results showed that all bees 
dosed with 2000, 1600, 800, or 400 μg OA per bee died after 72 h.  Bees subjected to the 
100 μg OA per bee dose survived longer than 72 h and had mortality similar to the 
control treatment.  My results roughly coincide with the recommended dose of OA per 
hive (≤ 2 g) because doses ≤ 100 μg OA per bee in my laboratory bioassays did not cause 
significant mortality.      
My data are significant because they quantify the dosage-mortality relationships 
for populations of both mites and bees that have not been exposed to OA.  My data will 
facilitate future comparisons of toxicity if mite resistance to OA becomes evident.  
Further, these basic toxicological properties of the compound will help guide scientists in 
developing techniques for delivering optimum dosages to the parasite and its host.   
  
Table 1.1 – Honey bee mortality responses to oxalic acid dihydrate when topically applied to bee abdomens in acetone 
and Varroa destructor mortality responses in glass-vial residual bioassays.  
Honey bee 
mortality  n Slope ± SE 
LD10 (95% CL)  
(μg per bee) 
LD50 (95% CL) 
(μg per bee) 
LD90 (95% CL) 
(μg per bee) 
24 h 280 2.87 ± 0.54 564.05 (95.22 to 877.92) 1,575.85 (1,087.44 to 2,962.72) 4,402.6 (2,541.78 to 48,848.75) 
48 h 280 3.96 ± 0.54 176.68 (120.36 to 225.54) 372.01 (306.78 to 439.88) 783.27 (643.5 to 1,042.56) 
Mite 
mortality  n Slope ± SE 
LC10 (95% CL) 
(μg per 20 mL vial) 
LC50 (95% CL) 
(μg per 20 mL vial) 
LC90 (95% CL) 
(μg per 20 mL vial) 
24 h 320 2.28 ± 0.35 1.4 (0.63 to 2.26) 5.12 (3.47 to 7.0) 18.69 (13.14 to 31.7) 
 
 
 
39
 
 40
 
Chapter 2 
 
Using fall treatments with oxalic acid to reduce Varroa mite populations in the 
North Central Region of the United States 
 
Abstract 
 Field trials were conducted on 52 honey bee colonies to quantify the efficacy of 
oxalic acid (OA) against Varroa mites in the North Central Region (NCR) of the United 
States.  I performed the experiment in November 2004 on colonies that were located in 3 
apiaries near Lincoln, NE.  The experimental colonies had 1 or 2 hive bodies (24.4 cm 
deeps) and contained less than 2 frames of brood.  I randomly assigned the Varroa-
infested colonies to 3 treatment groups: 1) trickle OA, 2) spray OA, and 3) untreated.  For 
the trickle treatment, I applied 50 mL of a 3.5% OA sugar water solution to both single 
and double story colonies using a 100 mL syringe (n = 17).  For the spray treatment, I 
applied 50 mL of a 3.5% OA sugar water solution to both single and double story 
colonies by directly spraying the adult bee cluster from above and below using a 1 L, 
non-pressurized sprayer (n = 18).  The experiment also included a group of untreated 
(control) colonies (n = 17).  I determined the pre- and post-treatment Varroa infestation 
levels for all colonies and calculated the percentage reduction in Varroa infestation 18 
days post-treatment.  The trickle treatment reduced Varroa infestation by 77.3 ± 14.1% 
when compared to untreated colonies.  The spray treatment reduced Varroa infestation by 
80.2 ± 14.0% when compared to untreated colonies.  The effectiveness of the trickle and 
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spray treatments was not significantly different.  I conclude that OA is a viable treatment 
method for Varroa mites in the NCR of the United States.   
 
Introduction 
Honey bee colonies located in the North Temperate Zone (includes Great Britain, 
Europe, northern Asia, and North America) decelerate brood rearing in autumn to prepare 
for winter.  In Nebraska, honey bee colonies have minimal brood by November, and by 
December, most colonies are broodless.  The broodless condition of honey bee colonies 
located in temperate climate zones is ideal for OA application because OA does not kill 
mites in sealed brood cells (Schuster and Schürzinger 2003).  Oxalic acid is most 
effective in broodless colonies because Varroa mites in brood cells are not exposed to 
treatments.  During broodless periods, all mites are phoretic on adult bees and vulnerable 
to treatment.  
The objective of this study was to investigate the usefulness of OA for reducing 
Varroa mite populations in broodless colonies in the NCR of the United States.  At the 
time of this study, OA’s efficacy had not been tested in the United States.  In contrast, 
numerous field studies that quantified the efficacy of OA on broodless colonies had been 
published in the European literature and report ~90% efficacy against Varroa when using 
either the trickle or spray treatment methods (Imdorf et al. 1995, Charrière and Imdorf 
2002, Nanetti et al. 2003, Charrière et al. 2004).  My goal was to test the hypothesis that 
OA would have an efficacy of ~90% against Varroa mites as reported in the European 
literature. 
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Materials and Methods 
Identification of experimental hives 
I established 52 experimental colonies in 3 apiaries near Lincoln, NE in 
November 2004.  The experimental hives were 1 or 2 stories (24.4 cm deeps) and 
contained less than 2 frames of brood.   
 
 Treatment and data collection   
I randomly assigned the Varroa-infested colonies to 3 treatment groups: 1) trickle 
OA, 2) spray OA, and 3) untreated.  I collected approximately 300 adult bees in alcohol 
from the 52 experimental hives on November 3rd, applied the OA treatments on 
November 4th, and collected the post-treatment alcohol samples on November 22nd, 2004.  
I estimated the pre- and post-treatment Varroa infestation levels using the alcohol wash 
method (Shimanuki and Knox 2000).     
For the trickle treatment, I applied 50 mL of a 3.5% OA sugar water (sugar:water) 
(1:1) (w:w) solution to both single and double story colonies using a 100 mL syringe (n = 
17).  I trickled the OA solution from above the frames between each occupied bee-way 
and made an effort to maximize contact with the adult bee population.  For the spray 
treatment, I applied 50 mL of a 3.5% OA sugar water solution (sugar:water) (1:1) (w:w) 
to both single and double story colonies by directly spraying the adult bee cluster from 
above and below using a 1 L, non-pressurized sprayer (n = 18).  The untreated (control) 
colonies were left untouched (n = 17).  I chose to treat the colonies with 50 mL of a 3.5% 
OA sugar water solution based on methods described by Rademacher and Harz (2006).  
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I inserted sticky boards and Checkmite+® strips in the hives from 2 of the 
apiaries (n = 25) on December 9th and removed them on December 13th, 2004.  The 
experimental mite populations had not previously exhibited coumaphos resistance.  I used 
the sticky board counts to determine the remaining mite populations in the experimental 
hives 35 days post-treatment.   
 
Experimental design and statistical analysis 
I designed my experiment as a randomized complete block design (RCBD) 
blocked by the apiaries in which the experimental hives were located (n = 3) to account 
for variance in the pre-treatment Varroa mite infestation levels.  I used mites-per-100 
adult bees as a response variable to test for differences in Varroa infestation between pre- 
and post-treatment experimental hives.  I used the percentage reduction in Varroa 
infestation 18 days post-treatment as another response variable.  For the final response 
variable, I examined the number of mites remaining 35 days post-treatment in hives 
treated with Checkmite+® strips and fitted with sticky boards.   
 I analyzed the data using PROC MIXED (SAS Institute 2006), and I separated 
means using a t-test (α = 0.05).  I assumed random blocks, although the assumption of 
fixed blocks did not change the results.   I applied the Kenwood-Rogers degrees of 
freedom adjustment, and used PROC UNIVARIATE and PROC GPLOT (SAS Institute 
2006) to verify my assumptions of normality and constant variance.   
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Results 
My assumptions of normality and constant variance were met.  I used the Shapiro-
Wilk test in the UNIVARIATE procedure of SAS to verify normality.  The Shapiro-Wilk 
test indicated that my data were normal (P = 0.3726) when using either mites-per-100 
adult bees or percentage reduction in Varroa infestation as response variables.  In 
addition, a symmetric box-plot and a straight-lined normal probability plot confirmed 
normality.  A plot of the residual versus the predicted values revealed no obvious patterns 
and was indicative of data that had constant variance.   
 
RCBD with mites-per-100 adult bees as the response variable 
I split the 3 treatment groups (trickle OA, spray OA, and untreated) into their pre- 
and post-treatment counterparts for this analysis.  This resulted in 6 treatment estimates 
(pre-trickle, pre-spray, pre-untreated, post-trickle, post-spray, and post-untreated).  The 
post-treatment estimates are derived from alcohol samples taken 18 days after the pre-
treatment alcohol samples.  The treatment effect was significant (F = 3.71, df = 5, 96.1, P 
= 0.0041).  A summary of the treatment estimates reported as mites-per-100 adult bees is 
provided in Table 2.1.  As illustrated in Table 2.1, the pre-trickle, pre-spray, and pre-
untreated experimental colonies had Varroa infestations ranging from 7.8 to 11.4 mites-
per-100 bees and were not significantly different from each other.  In contrast, both the 
18 d post-trickle and 18 d post-spray treatments had significantly fewer mites than the 18 
d post-treatment group that received no treatment (t = 2.52, df = 96, P = 0.0135) (t = 2.76, 
df = 96.1, P = 0.0070).  The 18 d post-trickle and 18 d post-spray Varroa infestations 
were not significantly different (t = 0.21, df = 96.1, P = 0.8310).   
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RCBD with percentage reduction in Varroa infestation 18 days post-treatment as the 
response variable 
 
The treatment effect was significant (F = 20.87, df = 2, 47.1, P = 0.0001).  See 
Table 2.2 for a summary of the treatment estimates reported as percentage reduction in 
Varroa infestation 18 days post-treatment.  The trickle OA treatment significantly 
reduced Varroa infestation by 77.3 ± 14.1% when compared to untreated colonies (t = 
5.48, df = 46.8, P = 0.0001).  Similarly, the spray OA treatment significantly reduced 
Varroa infestation by 80.2 ± 14.0% when compared to untreated colonies (t = 5.72, df = 
47.2, P = 0.0001).  The effectiveness of the trickle OA and spray OA treatments were not 
significantly different (t = 0.21, df = 47.2, P = 0.8377). 
 
RCBD with the number of mites remaining 35 days post-treatment as the response 
variable 
 
I used the sticky board counts for mites falling during the first 4 days after 
CheckMite+® application to determine the remaining mite populations in a portion of the 
experimental hives 35 days post-treatment.  The treatment effect was significant (F = 
13.59, df = 2, 21.4, P = 0.0002).  See Table 2.3 for a summary of the number of mites 
remaining 35 days post-treatment for each group.  The trickle OA treatment significantly 
reduced Varroa infestation by 268.4 ± 60.4 mites when compared to untreated colonies (t 
= 4.44, df = 21, P = 0.0002).  Similarly, the spray OA treatment significantly reduced 
Varroa infestation by 278.2 ± 60.8 mites when compared to untreated colonies (t = 4.58, 
df = 21.5, P = 0.0002).  The number of mites remaining in the trickle OA and spray OA 
treatment colonies were not significantly different (t = 0.16, df = 21.5, P = 0.8737). 
 
 46
 
Discussion 
I accept my hypothesis that OA would have an efficacy of ~90% against Varroa 
mites in the NCR of the United States.  The trickle OA and spray OA treatments 
significantly reduced Varroa infestation by 77.3% (95% CI = 48.9 to 105.7%) and 80.2% 
(95% CI = 52.0 to 108.4%) when compared to untreated colonies, respectively.  Although 
not statistically different, my results showed OA’s average efficacy to be 10 to 13% 
lower than the European results which indicated ~90% efficacy against Varroa when 
using either the trickle or spray treatment methods on broodless colonies.  One possible 
explanation as to why OA’s efficacy was numerically lower in my study than European 
studies is that I waited 18 days to take the post-treatment alcohol samples.  Several of the 
colonies had small patches of brood that may have increased Varroa infestation when 
they eclosed over the 18 day period between pre- and post-treatment samples.  Perhaps I 
did achieve ~90% efficacy against Varroa mites on adult bees at the time of treatment, 
and the efficacy by day 18 was underestimated due to Varroa mites emerging from 
brood.    
 The effectiveness of the trickle OA and spray OA treatments was not significantly 
different.  However, the trickle method may be preferable because it was less time and 
labor intensive yet had equivalent efficacy when compared to the spray method.  It took 
about 1.5 minutes to treat a colony using the trickle method and about 5 minutes to treat a 
colony using the spray method.  This includes removal of the lid and inner cover, 
application of OA, and reassembly of the hive.     
My results reveal that the trickle OA and spray OA treatments significantly 
reduced Varroa infestation regardless of the response variable modeled (mites-per-100 
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bees, percentage reduction in Varroa infestation 18 days post-treatment, or the number of 
mites remaining 35 days post-treatment).  Furthermore, 77.3 to 80.2% reduction in 
Varroa infestation is comparable to the efficacies of other Varroa control products on the 
market.  I conclude that OA is a viable treatment method for Varroa mites in the NCR of 
the United States.   
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Table 2.1 – Treatment estimates with mites-per-100 adult bees as 
the response variable.  Estimates with different letters indicate 
significant differences (t-test, α = 0.05). 
Treatment Estimate ± Standard error n 
Pre-trickle 11.4 ± 5.6 a 17 
Pre-spray   7.8 ± 5.6 a 18 
Pre-untreated 10.8 ± 5.6 a 17 
18 d Post-trickle*   1.8 ± 5.6 b 17 
18 d Post-spray   1.1 ± 5.6 b 18 
18 d Post-untreated 10.5 ± 5.6 a 17 
* 18 d = 18 days post-treatment 
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Table 2.2 – Treatment estimates with percentage reduction in Varroa 
infestation 18 days post-treatment as the response variable.  
Estimates with different letters indicate significant differences (t-test, 
α = 0.05). 
Treatment Estimate ± Standard error n 
Trickle OA 79.1 ± 14.4 a 17 
Spray OA 82.0 ± 14.1 a  18 
Untreated   1.8 ± 14.4 b 17 
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Table 2.3 – Treatment estimates with the number of mites 
remaining 35 days post-treatment as the response variable.  
Estimates with different letters indicate significant differences 
(t-test, α = 0.05). 
Treatment Estimate ± Standard error n 
Trickle OA           31.9 ± 47.8 a*  8 
Spray OA           22.1 ± 44.6 a   9 
Untreated       300.3 ± 47.8 b  8 
* The estimates represent the remaining mite populations 35 
days post-treatment that were recovered from sticky boards 
left in hives for 4 days with Checkmite+® strips present  
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Chapter 3 
 
Using summer oxalic acid treatments to reduce Varroa mite populations in colonies 
containing brood 
 
Abstract 
I conducted a field trial on 46 honey bee colonies to determine the efficacy of 
oxalic acid (OA) against Varroa mites in hives containing brood.  The experimental hives 
were single story, queenright, and contained all stages of worker brood.  I randomly 
assigned the experimental hives to 4 treatment groups: 1.) untreated or control, 2.) 2.0% 
OA, 3.) 3.5% OA, and 4.) 6.0% OA.  For the OA treatments, I trickled 50 mL of a 2.0%, 
3.5%, or 6.0% OA sugar water solution in the hives using a 100 mL syringe.  Each 
colony was treated 3 times at 1 week intervals.  The experiment also included a group of 
untreated colonies.  I collected approximately 300 adult bees in alcohol to estimate the 
pre- and post-treatment Varroa infestation level on adult bees.  I measured the square 
inches of capped worker brood, counted the number of frames that the adult bee cluster 
occupied, and examined both worker and drone bee pupae from each hive.  I counted the 
number of adult female Varroa mites on excised bee pupae to estimate the pre- and post-
treatment Varroa infestation levels in brood.  I also weighed the hives at the end of the 
study to quantify the impact of OA treatment on weight gain.  Repeated applications of 
OA did not significantly reduce the Varroa infestation on adult bees or in brood 
regardless of the concentration applied.  The number of frames of adult bees, the square 
inches of capped worker brood, and the average weight-per-hive were not negatively 
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affected by repeated applications of OA.  My results do not support the use of OA as a 
summer treatment when colonies contain expanded brood nests.  Although repeated 
treatments exhibited no harmful effects on bees, the paucity of significant mite 
population suppression indicates that repeated treatments are not useful in a Varroa 
management program.  
 
Introduction 
The broodless condition of honey bee colonies located in temperate climate zones 
is ideal for OA application because OA does not kill mites in sealed brood cells (Schuster 
and Schürzinger 2003).  Oxalic acid is most effective in broodless colonies because 
Varroa mites in brood cells are not exposed to treatments.  During broodless periods, all 
mites are phoretic on adult bees and vulnerable to treatment.  
The leading objective of the current study was to investigate the usefulness of 
repeated mid-summer applications of OA for reducing Varroa mite populations in 
colonies containing expanded brood nests.  While numerous studies of Varroa control 
with OA have been conducted in Europe, Asia, and Canada, few studies have been 
conducted in the United States.  Most studies report ~90% efficacy against Varroa when 
using either the trickle or spray treatment methods (Imdorf et al. 1995, Charrière and 
Imdorf 2002, Nanetti et al. 2003, Charrière et al. 2004, Rademacher and Harz 2006).  
Schuster and Schürzinger (2003) reported that a single application of OA does not kill 
mites in sealed brood cells.  My goal was to test the hypothesis that repeated applications 
of OA would significantly reduce Varroa mite populations in colonies containing brood.  
My theory was that by applying OA 3 times at one week intervals, mites in sealed brood 
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cells would eventually come in contact with OA as adult bees emerged over the 14 day 
treatment period and mites became phoretic on adult bees.  I wanted to establish the 
efficacy of 2.0%, 3.5%, and 6.0% OA sugar water solutions.  I hypothesized that the 
efficacy of OA against Varroa would increase as the concentration of the OA solution 
increased, and that 3 successive treatments at 7 day intervals would expose most of the 
Varroa population to OA.  My final objective was to quantify the impact of repeated 
applications of OA on overall colony health by measuring the square inches of capped 
worker brood, by counting the number of frames containing adult bees, and by weighing 
the colonies at the end of the study.  
 
Materials and Methods 
Identification of experimental hives 
I established 46 Varroa-infested honey bee colonies in 2 apiaries at the University 
of Nebraska-Lincoln’s Agricultural Research and Development Center (ARDC) near 
Mead, NE as experimental units for this study.  The experimental hives were single story 
Langstroth beehives (24.4 cm deep hive body) with a queen excluder and 1 or 2 supers 
(16.8 cm deep).  The experimental colonies contained 3 to 6 frames of brood, a young 
Carniolan or Italian queen, and all frames were covered with bees.  
 
Treatment and data collection 
 I randomly assigned the 46 experimental hives to 4 treatment groups: 1.) 
untreated or control, 2.) 2.0% OA, 3.) 3.5% OA, and 4.) 6.0% OA.  The hives were 
queenright and contained all stages of worker brood (eggs, larvae, pupae).  Not all hives 
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contained drone brood.  I collected approximately 300 adult bees in alcohol to estimate 
the pre-treatment Varroa infestation level on adult bees (July 12).  I applied the OA 
treatments on July 13, 19, and 27.  I collected approximately 300 adult bees in alcohol to 
estimate the post-treatment Varroa infestation level on adult bees (August 9).         
 I measured the square inches of capped worker brood, counted the number of 
frames that the adult bee cluster occupied, and excised ~300 worker bee pupae and ~90 
drone bee pupae from each hive (July 12 and August 9).  I counted the number of adult 
female Varroa mites on excised bee pupae to estimate the pre- and post-treatment Varroa 
infestation levels in brood.  I weighed the hives at the end of the study to quantify the 
impact of OA treatment on weight gain (August 9).   
 For the OA treatments, I trickled 50 mL of either a 2.0%, 3.5%, or 6.0% OA sugar 
water (sugar:water) (1:1) (w:w) solution over the cluster of bees using a 100 mL syringe.  
I trickled 5-6 mL of the OA solutions between each occupied bee-way and made an effort 
to maximize contact with the adult bee population.  Each colony was treated 3 times at 1 
week intervals (July 13, 19, and 27).  The untreated (control) colonies were left 
untouched.  I chose to treat the hives with 50 mL of the OA sugar water solutions based 
on European results reported by Rademacher and Harz (2006).   
 
Experimental design and statistical analysis 
 I designed my experiment as an randomized complete block design (RCBD).  I 
blocked by apiary (n = 2) in which the experimental hives were located to account for 
variance in the pre-treatment Varroa mite infestation levels.  I used mites-per-100 adult 
bees pre- and post-treatment, percentage reduction in Varroa infestation 28 days post-
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treatment, and mites-per-100 excised worker and drone pupae pre- and post-treatment as 
response variables.  Other response variables included the number of frames of adult bees 
in each hive pre- and post-treatment, the square inches of capped worker brood pre- and 
post-treatment, and the post-treatment weight-per-hive. 
I analyzed the mites-per-100 adult bee data, the mites-per-100 excised worker 
pupae data, the mites-per-100 excised drone pupae data, and the square inches of capped 
worker brood data using PROC GLIMMIX (SAS Institute 2006) and separated means 
using a t-test (α = 0.05).  I fit a generalized linear model (GLM) for each of the 
aforementioned response variables using a normal distribution.  I also assumed random 
blocks, although the assumption of fixed blocks did not change the results.  I framed my 
data as a factorial with dose and time as factors.  Time had 2 levels: pre- and post-
treatment.  Dose had 4 levels: 0 (untreated), 2.0% OA, 3.5% OA, and 6% OA.  For the 
above analyses, there were 8 total treatment combinations (pre-untreated, pre-2.0% OA, 
pre-3.5% OA, pre-6.0% OA, post-untreated, post-2.0% OA, post-3.5% OA, and post-
6.0% OA).  I applied the ‘group=dose’ option in PROC GLIMMIX to fit a separate 
variance for each dosage of OA.  I used PROC UNIVARIATE (SAS Institute 2006) to 
verify my assumption of normality.   
I also analyzed the number of frames of adult bees data using PROC GLIMMIX 
(SAS Institute 2006) and separated means using a t-test (α = 0.05).  This data set differed 
from the abovementioned response variables because the data were frame counts (1 to 9 
frames).  For this response variable, I fit a GLM and implemented the Poisson 
distribution in PROC GLIMMIX.  
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 I analyzed the percentage reduction in Varroa infestation 28 days post-treatment 
data and the post-treatment weight-per-hive data using PROC GLIMMIX (SAS Institute 
2006) and separated means using a t-test (α = 0.05).  I fit a GLM for the percentage 
reduction and weight-per-hive response variables using a normal distribution.  I assumed 
random blocks, although the assumption of fixed blocks did not change the results.  I 
considered 4 treatments for the percentage reduction in Varroa infestation 28 days post-
treatment data (untreated, 2.0% OA, 3.5% OA, and 6.0% OA).  The percentage reduction 
in Varroa infestation was calculated for each hive using the pre- and post-treatment 
mites-per-100 adult bee data.  I considered 4 treatments for the post-treatment weight-
per-hive data (post-untreated, post-2.0% OA, post-3.5% OA, and post-6.0% OA).  I 
applied the ‘group=treatment’ option in PROC GLIMMIX to fit a separate variance for 
each treatment.  I used PROC UNIVARIATE (SAS Institute 2006) to verify my 
assumption of normality.   
 
Results 
My assumption of normality was met for all response variables for which I fit a 
GLM using a normal distribution.  These data sets produced a symmetric box-plot and a 
straight-lined normal probability plot that confirmed normality.  A plot of the residual 
versus the predicted values revealed a problem with non-constant variance.  The 
‘group=dose’ option and the ‘group=treatment’ option that I employed in PROC 
GLIMMIX fixed the non-constant variance issue.  After fitting a separate variance for 
each treatment, a plot of the residual versus the predicted values revealed no obvious 
patterns and was indicative of data that had constant variance.   
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Number of bees collected for adult and brood samples 
The average number of adult bees collected in alcohol was 306.8 ± 41.2 (n = 92) 
for each pre- and post-treatment sample.  The average was calculated using both pre- and 
post-treatment alcohol samples for each hive (46 experimental hives X 2 sample times = 
92 adult bee alcohol samples).  The average number of worker and drone brood cells 
excised for pre- and post-treatment sample is shown in Table 3.1.   
 
RCBD with mites-per-100 adult bees as the response variable 
 There was no significant time*dose interaction (F = 0.18, df = 3, 83, P = 0.9091), 
and therefore, the main effects of time and dose were considered.  The time effect was 
significant (F = 20.69, df = 1, 83, P = 0.0001).  Prior to OA treatment, the hives had 2.5 ± 
0.5 more mites-per-100 adult bees than after OA treatment regardless of the OA 
concentration applied (t = 4.55, df = 83, P = 0.0001).  The dose effect was not significant 
(F = 1.13, df = 3, 83, P = 0.3411).  See Table 3.2 for the treatment estimates with mites-
per-100 adult bees as the response variable.   
 
RCBD with percentage reduction in Varroa infestation 28 days post-treatment as the 
response variable   
 
 The treatment effect was not significant at α = 0.05 (F = 1.99, df = 3, 41, P = 
0.1302).  See Table 3.3 for the treatment estimates with percentage reduction in Varroa 
infestation 28 days post-treatment as the response variable.  Although the treatment effect 
was not significant at α = 0.05, it is important to note that when using α = 0.1, the 6.0% 
OA treatment significantly reduced Varroa infestation by 35.4 ± 18.6% when compared 
to untreated colonies (t = 1.90, df = 41, P = 0.0640).  Similarly, when using the α = 0.1 
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significance level, the 6.0% OA treatment significantly reduced Varroa infestation by 
29.0 ± 16.1% when compared to the 2.0% OA treatment (t = 1.80, df = 41, P = 0.0792).   
 
RCBD with mites-per-100 excised worker pupae as the response variable 
 There was significant time*dose interaction (F = 2.30, df = 3, 63, P = 0.0858) at 
the α = 0.1 significance level, and therefore, the simple effects of time and dose were 
considered.  When only considering the post-treatment time effect, the untreated hives 
had 0.7 ± 0.4 more mites-per-100 excised worker pupae than the hives that received the 
3.5% OA treatment (t = 2.01, df = 63, P = 0.0484).  When only considering the post-
treatment time effect, the untreated hives had 0.7 ± 0.3 more mites-per-100 excised 
worker pupae than the hives that received the 6.0% OA treatment (t = 2.18, df = 63, P = 
0.0329).  When only considering the pre-treatment time effect, the hives slated to receive 
the 2.0% OA treatment had 0.7 ± 0.3 more mites-per-100 excised worker pupae than the 
hives slated to receive the 6.0% OA treatment (t = 2.30, df = 63, P = 0.0245).  When only 
considering the pre-treatment time effect, the hives slated to receive the 3.5% OA 
treatment had 0.7 ± 0.3 more mites-per-100 excised worker pupae than the hives slated to 
receive the 6.0% OA treatment (t = 2.35, df = 63, P = 0.0220).  When only considering 
the hives that received the 3.5% OA treatment, there were 1.0 ± 0.4 more mites-per-100 
excised worker pupae prior to OA treatment than after OA treatment (t = 2.92, df = 63, P 
= 0.0049).  See Table 3.4 for the treatment estimates with mites-per-100 excised worker 
pupae as the response variable. 
 
 
 
59  
RCBD with mites-per-100 excised drone pupae as the response variable 
There was no significant time*dose interaction (F = 0.32, df = 3, 41, P = 0.8114), 
and therefore, the main effects of time and dose were considered.  The time effect was 
not significant (F = 1.23, df = 1, 41, P = 0.2734).  The dose effect was also not significant 
(F = 0.36, df = 3, 41, P = 0.7826).  See Table 3.5 for the treatment estimates with mites-
per-100 excised drone pupae as the response variable. 
 
RCBD with the number of frames of adult bees in each hive as the response variable 
There was no significant time*dose interaction (F = 0.10, df = 3, 83, P = 0.9587), 
and therefore, the main effects of time and dose were considered.  The time effect was 
not significant (F = 1.02, df = 1, 83, P = 0.3184).  The dose effect was not significant (F 
= 0.13, df = 3, 83, P = 0.9443).  See Table 3.6 for the treatment estimates with the 
number of frames of adult bees in each hive as the response variable. 
 
RCBD with the square inches of capped worker brood in each hive as the response 
variable 
 
There was no significant time*dose interaction (F = 0.42, df = 3, 83, P = 0.7390), 
and therefore, the main effects of time and dose were considered.  The time effect was 
not significant (F = 1.37, df = 1, 83, P = 0.2444).  The dose effect was not significant (F 
= 0.85, df = 3, 83, P = 0.4731).  See Table 3.7 for the treatment estimates with the square 
inches of capped worker brood in each hive as the response variable. 
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RCBD with the weight-per-hive (lbs) 28 days post-treatment as the response variable 
The treatment effect was not significant (F = 1.70, df = 3, 41, P = 0.1819).  See 
Table 3.8 for the treatment estimates with the weight-per-hive 28 days post-treatment as 
the response variable.  
 
Discussion 
I reject my hypothesis that repeated applications of OA would significantly 
reduce Varroa mite populations in colonies containing brood.  There was an overall 
percentage reduction in the Varroa mite populations on adult bees regardless of treatment 
(Table 3.3).  The mites-per-100 adult bee data coincide with the percentage reduction in 
Varroa infestation data as the hives had 2.5 ± 0.5 more mites-per-100 adult bees prior to 
OA treatment than after OA treatment.  Again, treatment with OA did not significantly 
reduce the number of mites on adult bees regardless of the concentration applied (Table 
3.2). 
The 6.0% OA treatment significantly reduced Varroa infestation by 35.4 ± 18.6% 
when compared to untreated colonies (α = 0.1 level of significance).  Similarly, the 6.0% 
OA treatment significantly reduced Varroa infestation by 29.0 ± 16.1% when compared 
to the 2.0% OA treatment (α = 0.1 level of significance).  I do not consider the above 
treatment differences important because both the probability of Type I error and the 
variation in percentage reduction are large.  Furthermore, the percentage reduction 
achieved with the 6.0% OA treatment is significantly less than other Varroa control 
products on the market.   
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 I am puzzled by the result that the untreated colonies had a 37.4 ± 17.2% decrease 
in Varroa infestation.  One possible reason that the Varroa population decreased on adult 
bees in control colonies is that one of the experimental apiaries was exposed to full 
sunlight for the majority of the day (n = 32).  The average maximum daily temperature 
during the experiment was 35.1 ± 2.6°C (95.1 ± 4.6°F).  Aliano and Ellis (2005a) report 
that heat significantly increases the number of mites that fall from adult bees at 
temperatures ≥ 35°C.  I noticed large clusters of adult bees hanging on the outside of the 
colonies above the entrances that were fanning air currents to cool the colonies during hot 
periods of the day.  Perhaps mites fell from the adult bee clusters outside of the hive and 
were not able to reenter the colony.  Another possibility is that the internal colony 
temperature was not being adequately controlled by the bee population and mites fell or 
were injured due to extreme temperatures.  One problem with the above explanations is 
that there was a significant decrease in Varroa infestation in the control colonies when 
only considering the apiary that had moderate shade (n = 14).   
A final explanation for why the Varroa population decreased on adult bees in the 
control colonies is that mites may have migrated to drone brood as it became available 
during the study.  Approximately half of the colonies did not have appropriately aged 
drone brood to sample for mites at the end of the study (n = 21) (pupae with purple eyes) 
but the majority of the colonies had recently capped drone brood present. 
I reject my hypothesis that the efficacy of OA would increase as the concentration 
of the OA solution increased in colonies containing brood.  As Table 3.3 illustrates, the 
efficacy of OA numerically increased as the OA concentration increased, but the 
differences were not significant.  It is interesting that the treatment standard errors 
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decreased as the OA concentration increased.  The fact that the variance in Varroa 
infestation went down as OA concentration increased makes biological sense because 
more of the mites theoretically died as more OA was applied. 
The analysis of the mites-per-100 excised worker pupae data is difficult to 
interpret because there were significantly more mites in the hives slated to receive the 
2.0% and 3.5% OA treatment than the hives slated to receive the 6.0% OA treatment.  
Although the untreated hives had 0.7 more mites-per-100 excised worker pupae than the 
hives that received the 3.5% OA treatment or the 6.0% OA treatment, the differences 
may be fictitious because the pre-treatment Varroa infestation in worker brood was not 
constant among the treatments (Table 3.4).  In contrast, the mites-per-100 excised drone 
pupae data indicates that the Varroa infestation in drone brood was not significantly 
different between the treatment groups before or after OA application (Table 3.5).  I place 
more importance on the mites-per-100 excised drone pupae data because Varroa mites 
preferentially parasitize drone brood over worker brood, and drone brood is often 8-10 
times more infested than worker brood (Fuchs 1990).  Similar to the mites-per-100 adult 
bee data and the percentage reduction in Varroa infestation data, the mites-per-100 
excised drone pupae data indicates that OA did not significantly reduce Varroa mite 
populations in colonies containing brood.     
The final objective of this experiment was to quantify the impact of repeated 
applications of OA on overall colony health by measuring the square inches of capped 
worker brood, by counting the number of frames containing adult bees, and by weighing 
the colonies at the end of the study.  As illustrated in Tables 3.6, 3.7, and 3.8, the number 
of frames of adult bees, the square inches of capped worker brood, and the average 
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weight-per-hive were not significantly influenced by repeated applications of OA, 
regardless of the OA concentration.  My results indicate that summer bees can tolerate 
larger amounts of OA than reported in the literature for autumn or winter bees.  Liebig 
(1998) and Charrière (2001) quantified the impact on autumn or winter colonies when 
applying OA solutions with concentrations greater than 5% and described significant 
adult bee mortality, poor over-wintering ability, and impaired spring development.  My 
data suggests that 3 summer trickle treatments with 6.0% OA at one week intervals did 
not have a negative impact on colony health.    
I conclude that repeated applications of OA did not significantly reduce Varroa 
mite populations in honey bee colonies when brood was present.  My results confirm the 
observations that OA is less effective when significant brood is present (Fuchs 1990, 
Gregorc 2001).  One possible reason for the poor efficacy of OA in the presence of brood 
may be that brood provides a robust buffer that counteracts phoretic mite mortality.  
Another reason for the poor efficacy of mid-summer use of OA may be inadequate 
distribution of OA among the adult bee population.  Unlike OA treatments in the fall or 
early winter, mid-summer bees do not cluster, which may result in OA missing the 
majority of adult bees.  Furthermore, mid-summer use of OA may result in rapid 
evaporation of the OA crystals due to heat and excessive fanning of the hive by adult 
bees for cooling purposes.  My results do not support the mid-summer use of OA to 
reduce Varroa populations which agrees with observation in Europe (Rademacher and 
Harz 2006).   
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Table 3.1 – Average number of brood cells excised for pre- and 
post-treatment sample.  The estimates were calculated using both 
the pre- and post-treatment brood samples for each hive. 
Brood type Estimate ± Standard error n* 
Worker 304.7 ± 75.6 86 
Drone   88.9 ± 38.1 60 
* 43 of the 46 experimental hives had available worker brood to sample  
* 30 of the 46 experimental hives had available drone brood to sample 
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Table 3.2 – Treatment estimates with mites-per-100 adult bees as the 
response variable.  The estimates represent the Varroa infestation of 
adult bees prior to and after treatment with OA.  Estimates with 
different letters indicate significant differences (t-test, α = 0.05). 
Treatment Estimate ± Standard error n 
*Pre-untreated 3.8 ± 1.4 a 12 
Pre-OA 2.0%  4.3 ± 1.5 a 12 
Pre-OA 3.5%  3.5 ± 1.5 a 11 
Pre-OA 6.0%  3.2 ± 1.2 a 11 
*Post-untreated 1.9 ± 1.4 b 12 
Post-OA 2.0%  1.6 ± 1.5 b 12 
Post-OA 3.5%  0.5 ± 1.5 b 11 
Post-OA 6.0%  0.9 ± 1.2 b 11 
* Average pre-treatment estimate summed over OA 
concentration = 3.7 ± 1.2 mites-per-100 adult bees 
* Average post-treatment estimate summed over OA 
concentration = 1.2 ± 1.2 mites-per-100 adult bees 
 
66  
Table 3.3 – Treatment estimates with percentage 
reduction in Varroa infestation 28 days post-treatment as 
the response variable.  Estimates with different letters 
indicate significant differences (t-test, α = 0.05). 
Treatment Estimate ± Standard error n 
Untreated 37.4 ± 17.2 a 12 
OA 2.0% 43.7 ± 14.5 a 12 
OA 3.5% 55.7 ± 13.8 a 11 
OA 6.0% 72.8 ± 8.0 a 11 
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Table 3.4 – Treatment estimates with mites-per-100 excised 
worker pupae as the response variable.  The estimates represent 
the Varroa infestation of worker brood prior to and after 
treatment with OA.  Estimates with different letters indicate 
significant differences (t-test, α = 0.05).   
Treatment Estimate ± Standard error n3 
1Pre-untreated 0.8 ± 0.3 ab4 10 
Pre-OA 2.0%  1.3 ± 0.3 b 11 
Pre-OA 3.5%  1.3 ± 0.3 b 5 
Pre-OA 6.0%  0.6 ± 0.3 a 10 
2Post-untreated 1.0 ± 0.3 a 10 
Post-OA 2.0%  0.7 ± 0.3 ab 11 
Post-OA 3.5%  0.3 ± 0.3 b 5 
Post-OA 6.0%  0.4 ± 0.3 b 10 
1 Average pre-treatment estimate summed over OA concentration = 
1.0 ± 0.2 mites-per-100 excised worker pupae 
2 Average post-treatment estimate summed over OA concentration = 
0.6 ± 0.2 mites-per-100 excised worker pupae  
3 Hives with non-detectable mites pre- and post-treatment were 
eliminated from the analysis 
4 This table does not consider comparisons between treatments above 
and below the double line 
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Table 3.5 – Treatment estimates with mites-per-100 excised drone 
pupae as the response variable.  The estimates represent the Varroa 
infestation of drone brood prior to and after treatment with OA.  
Estimates with different letters indicate significant differences (t-test, 
α = 0.05).   
Treatment Estimate ± Standard error n3 
1Pre-untreated 10.6 ± 5.7 a 6 
Pre-OA 2.0%    8.6 ± 6.0 a 8 
Pre-OA 3.5%    9.6 ± 8.4 a 3 
Pre-OA 6.0%  12.5 ± 6.6 a 8 
2Post-untreated 10.6 ± 5.7 a 6 
Post-OA 2.0%    7.3 ± 6.0 a 8 
Post-OA 3.5%    2.0 ± 8.4 a 3 
Post-OA 6.0%    6.2 ± 6.6 a 8 
1 Average pre-treatment estimate summed over OA 
concentration = 10.3 ± 5.3 excised drone pupae 
2 Average post-treatment estimate summed over OA 
concentration = 6.5 ± 5.3 excised drone pupae 
3 Hives with zero mites pre- and post-treatment were 
eliminated from the analysis 
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Table 3.6 – Average number of frames of adult bees in each hive.  
Estimates with different letters indicate significant differences (t-test, 
α = 0.05). 
Treatment Estimate ± Standard error n 
*Pre-untreated 6.8 ± 0.8 a 12 
Pre-OA 2.0%  7.2 ± 0.8 a 12 
Pre-OA 3.5%  7.2 ± 0.8 a 11 
Pre-OA 6.0%  7.6 ± 0.8 a 11 
*Post-untreated 7.8 ± 0.8 a 12 
Post-OA 2.0%  8.0 ± 0.8 a 12 
Post-OA 3.5%  7.5 ± 0.8 a 11 
Post-OA 6.0%  7.8 ± 0.8 a 11 
* Average pre-treatment estimate summed over OA concentration = 
7.2 ± 0.4 frames of adult bees 
* Average post-treatment estimate summed over OA concentration = 
7.8 ± 0.4 frames of adult bees 
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Table 3.7 – Average square inches of capped worker brood in 
each hive.  Estimates with different letters indicate significant 
differences (t-test, α = 0.05). 
Treatment Estimate ± Standard error n 
*Pre-untreated 308.0 ± 39.7 a 12 
Pre-OA 2.0%  294.4 ± 47.8 a 12 
Pre-OA 3.5%  263.0 ± 50.6 a 11 
Pre-OA 6.0%  322.5 ± 40.7 a 11 
*Post-untreated 364.3 ± 39.7 a 12 
Post-OA 2.0%  332.0 ± 47.8 a 12 
Post-OA 3.5%  294.8 ± 50.6 a 11 
Post-OA 6.0%  314.2 ± 40.7 a 11 
* Average pre-treatment estimate summed over OA concentration = 
297.0 ± 32.9 square inches of worker brood 
* Average post-treatment estimate summed over OA concentration = 
326.3 ± 32.9 square inches of worker brood 
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Table 3.8 – Average weight-per-hive 28 days post-treatment.  
Estimates with different letters indicate significant differences 
(t-test, α = 0.05). 
Treatment Estimate (lbs) ± Standard error n 
Untreated 117.3 ± 23.5 a 12 
OA 2.0% 111.9 ± 23.2 a 12 
OA 3.5%   97.3 ± 22.1 a 11 
OA 6.0% 112.7 ± 22.1 a 11 
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Chapter 4 
 
Oxalic acid – a prospective tool for reducing Varroa mite populations in package 
bees: Part I – Laboratory evaluation 
 
Abstract 
 Numerous studies have investigated using oxalic acid (OA) to control Varroa 
mites in honey bee colonies.  In contrast, techniques for treating package bees with OA 
have not been investigated.  The goal of this study was to develop a protocol for using 
OA to reduce mite infestation in package bees.  I made 97 mini packages of Varroa-
infested adult bees.  Each package contained 1613 ± 18 bees, 92 ± 3 mites, and 
represented an experimental unit.  I prepared a 2.8% solution of OA by mixing 35 g OA 
with 1 L of sugar water (sugar:water) (1:1) (w:w).  Eight treatments were assigned to the 
packages based on previous laboratory bioassays which characterized the acute contact 
toxicity of OA to mites and bees.  I administered the treatments by spraying the OA 
solution directly on the bees through the mesh screen cage using a pressurized air brush 
and quantified mite and bee mortality over a 10 day period.  My results support applying 
an optimum volume of 3.0 mL of a 2.8% OA solution per 1000 bees to packages for 
effective mite control with minimal adult bee mortality.  The outcome of my research 
provides beekeepers and package bee shippers guidance for using OA to reduce mite 
populations in package bees. 
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Introduction 
Numerous studies have investigated using oxalic acid (OA) to control Varroa 
mites in honey bee colonies.  In contrast, techniques for treating package bees with OA 
have not been investigated.  A review of literature regarding the efficacy of OA 
(Rademacher and Harz 2006) indicates that broodless colonies are ideal for OA 
application.  Oxalic acid does not kill mites in sealed brood cells (Schuster and 
Schürzinger 2003), and it is less effective when brood is present (Fuchs 1990, Gregorc 
2001).  Oxalic acid is most effective in broodless colonies because Varroa mites are 
phoretic on adult bees, and mites inevitably come in physical contact with OA when it is 
applied. 
Treating package bees with OA is a logical extension of the usefulness of OA as a 
Varroa mite control agent because all mites present in packages are phoretic on adult 
bees.  The goal of this study was to develop a protocol for using OA to reduce mite 
infestation in package bees.  This study establishes an optimum volume of a 2.8% OA 
solution for spraying on package bees to provide effective mite control while minimizing 
adult bee mortality.  
 
Materials and Methods 
Stocking of packages 
 I shook 25 kg of Varroa-infested adult honey bees from 20 source colonies into a 
bulk bee box on the evening of May 25th, 2006.  The source colonies were located at the 
University of Nebraska-Lincoln’s Agricultural Research and Development Center 
(ARDC) near Mead, NE.  I had previously caged the queens from the source colonies to 
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ensure that all mites were phoretic on adult bees (May 5).  The source colonies were 2 or 
3 stories high and were composed of a mixture of Italian and Carniolan bees.  I added 1 
frame of honey, 2 frames of pollen and nectar, 1 frame of unsealed brood, and 1 frame 
with 15 caged queens to stabilize the bulk bee box.  In addition, I fit the bulk bee box 
with top feeders that contained 6 L of light syrup and 3 L of water.  I maintained the bulk 
box overnight to allow the bees to cluster and the mite population to become equally 
distributed.   
 The next day, I made 97 packages of adult bees by subdividing the adult bee 
population in the bulk bee box (May 6).  The dimensions of the packages were 10.2 cm 
long, 8.3 cm wide, and 17.8 cm high (Figure 4.1).  I provided each package with a 0.5 L 
scoop of adult bees.  Each package contained 1613 ± 18 bees and 92 ± 3 mites.  I moved 
the packages to a dark, air-conditioned laboratory where I fit each package with a 0.5 L 
top feeder containing light syrup (sugar:water) (1:1) (w:w).  I placed 3 large fans in the 
laboratory to remove CO2 and to prevent the packages from overheating.  The daily 
temperature and relative humidity inside the laboratory averaged 23 ± 2°C (n = 6) and 
63.6 ± 9% (n = 6), respectively. 
 
Determination of the OA concentration and volumes to apply to the packages 
The Canadian Honey Council has provided the American Beekeeping Federation 
their registration data packet to expedite the registration of OA in the United States.  As a 
result, the recommended concentration of the OA solution that will appear on the United 
States label will most likely be identical to the Canadian label.  Therefore, I chose to test 
one concentration of OA based on the Canadian treatment recommendations for honey 
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bee colonies.  The Canadian label recommends dissolving 35 g of OA dihydrate in 1 L of 
warm syrup made from a mixture of sugar and water (sugar:water) (1:1) (weight:volume) 
(Special Supplement 2005).  This mixture results in a 2.8% OA sugar water solution by 
weight (sugar:water) (1:1) (w:w). 
I used the bioassay data from chapter 1 to determine the maximum volume of OA 
to apply to the packages.  The bioassay data estimated the 48 hour LD50 for adult honey 
bees to be 372 µg per bee (95% CL = 307 to 440 µg per bee) (Table 1.1).  I picked a high 
volume of 15 mL of a 2.8% OA solution per package to approximate a dose that was 
slightly less than the 48 hour LD50 for adult honey bees (equivalent to 9.3 mL per 1000 
bees).  A volume greater than 15 mL may have resulted in the premature death of 
packages so I decided to err on the side of caution.  My calculations were as follows:  35 
g of OA in 1 L of sugar water results in approximately 0.035 g OA/mL solution.  15 mL 
of OA solution X 0.035 g OA/mL solution = 0.525 g OA per package (525,000 µg per 
package).  525,000 µg per package / 1618 bees per package = 325 µg per bee.   
I chose 8 volumes of OA to apply to the packages: 0, 1, 3, 5, 7, 9, 11, and 15 mL 
of a 2.8% OA solution per package.  The above volumes are equivalent to 0.0, 0.6, 1.8, 
3.1, 4.6, 5.4, 6.7, and 9.3 mL of a 2.8% OA solution per 1000 bees, respectively.   
 
Treatment and data collection 
 I randomly assigned the 97 packages to the 8 treatment groups defined above.  I 
prepared a 2.8% solution of OA by mixing 35 g OA with 1 L of sugar water (sugar:water) 
(1:1) (w:w).  I administered the treatments by spraying the OA solution directly on the 
bees through the mesh screen cage using a pressurized air brush (King Spark Hardware & 
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Tool Corporation, model AB-105, Taichung County, Taiwan) (Figure 4.2).  I pipetted the 
appropriate volume of OA solution into the air brush gravity cup (paint cup) for each 
treatment and sprayed the adult bee cluster until the solution was gone.  I made an effort 
to maximize OA contact with the adult bees by spraying both sides of the screen cages.   
I placed sticky boards in the packages prior to OA application to monitor mite 
fall.  I replaced the sticky boards 3, 6, and 10 days post-treatment to estimate 3, 6, and 10 
day Varroa mite mortality.  In addition, I recovered dead bees 3, 6, and 10 days post-
treatment by removing them from the packages (Figure 4.3).  I chilled the packages at 
2°C for 20 minutes to force the bees to cluster and facilitate dead bee recovery (3, 6, and 
10 days post-treatment).  The packages had a sliding screened side that allowed me to 
remove dead bees from the bottom of the packages while leaving the cluster of live bees 
undisturbed.  After counting the number of dead bees at each time interval, I washed the 
bees in alcohol to recover the mites that had fallen into the pile of dead bees instead of 
landing on the sticky boards below.  I added the number of mites collected on the sticky 
boards to the number of mites collected from the dead bees to estimate the Varroa mite 
mortality for each time interval.   
At the end of the experiment, I killed and counted the remaining bees in the 
packages by spraying them with 70% alcohol.  In addition, I recovered the remaining 
mites using the alcohol wash method (Shimanuki and Knox 2000).  I was able to 
calculate the total number of bees and mites present in each package prior to OA 
application by destructively sampling the packages at the end of the experiment.  
Specifically, I added the number of mites collected from sticky boards and dead bees 3, 6, 
and 10 days post-treatment to the number of mites collected from live bees at the end of 
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the experiment to calculate the total number of mites present in each package prior to 
experimentation.  Similarly, I added the number of dead bees collected 3, 6, and 10 days 
post-treatment to the number of live bees remaining at the end of the experiment to 
calculate the total number of bees present in each package prior to experimentation.  This 
enabled me to calculate the proportion of mites and bees killed in each package 3, 6, and 
10 days post-treatment.  The 97 packages contained a total of 9,309 mites and 162,934 
bees. 
 
Experimental design and statistical analysis 
 I designed my experiment as a completely randomized design (CRD).  I used the 
proportion of mites and bees killed 3, 6, and 10 days post-treatment as response variables.  
I used PROC GLIMMIX to analyze both the mite and bee proportion data and used a 
binomial response distribution (SAS Institute 2006).  I fit a generalized linear model 
(GLM) with a binomial response distribution implemented in PROC GLIMMIX.  I 
separated means using a t-test (α = 0.05).  In addition to the PROC GLIMMIX analysis, I 
fit the same model using the NLMIXED procedure (SAS Institute 2006) to calculate the 
lethal doses (LD’s) for both mites and bees 3, 6, and 10 days post-treatment. 
 
Results 
Lethal doses of OA for mites and bees 
 Tables 4.1 and 4.2 lists honey bee and Varroa mite mortality responses to a 2.8% 
OA solution when sprayed on package bees, respectively.  Note that Tables 4.1 and 4.2 
list the LD50 3, 6, and 10 days post-treatment.  In addition, Table 4.2 lists the LD90 and 
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LD95 for mites while Table 4.1 lists the LD10 and LD15 for honey bees because my 
objective was to choose a dose that provided effective mite control while minimizing 
adult bee mortality. 
 
 
CRD with the proportion of mites killed 3, 6, and 10 days post-treatment as the response 
variable 
 
I modeled the factors time, volume, and the time*volume interaction.  The 
time*volume interaction was not significant (F = 0.06, df = 14, 267, P = 1.0000).  The 
time effect was also not significant (F = 0.27, df = 2, 267, P = 0.7655), indicating that 
mite mortality 3 days post-treatment was not significantly different than mite mortality 6 
or 10 days post-treatment.  The volume effect was significant (F = 10.09, df = 7, 267, P = 
0.0001).  Table 4.3 lists the main effect estimates of the proportion of mites killed for 
each of the 8 volumes.  Volumes ≥ 3.1 mL of a 2.8% OA solution per 1000 bees resulted 
in ≥ 94% mite mortality.   In addition, increasing the volume above 3.1 mL per 1000 bees 
did not significantly increase mite mortality.  Figure 4.4 illustrates the Varroa mite 
mortality response to a 2.8% OA solution when sprayed on package bees.  The standard 
error bars were intentionally not included in Figure 4.4 because they overlap for each 
time interval and clutter the graph.  The standard error for each volume is listed in Table 
4.3.   
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CRD with the proportion of bees killed 3, 6, and 10 days post-treatment as the response 
variable 
 
I modeled the factors time, volume, and the time*volume interaction.  The 
time*volume interaction was not significant (F = 0.05, df = 14, 267, P = 1.0000).  The 
time effect was not significant (F = 2.61, df = 2, 267, P = 0.0756), indicating that bee 
mortality 3 days post-treatment was not significantly different than bee mortality 6 or 10 
days post-treatment.  The volume effect was significant (F = 7.67, df = 7, 267, P = 
0.0001).  Table 4.4 lists the main effect estimates of the proportion of bees killed for each 
of the 8 volumes.  In general, volumes ≥ 4.6 mL of a 2.8% OA solution per 1000 bees 
caused significant adult bee mortality when compared to untreated packages.  Figure 4.5 
illustrates the adult bee mortality response to a 2.8% OA solution when sprayed on 
package bees.  The standard error bars were intentionally not included in Figure 4.5 
because they overlap for each time interval and clutter the graph.  The standard error for 
each volume is listed in Table 4.4.   
 
Discussion 
 The data collected from this experiment indicate an optimum volume of a 2.8% 
OA solution that provides effective mite control while minimizing adult bee mortality 
when sprayed on package bees.  I recommend applying 3.0 mL of a 2.8% OA sugar water 
solution (sugar:water) (1:1) (w:w) per 1000 bees to packages for > 90% mite control and 
no significant bee mortality.  The OA solution should be applied to packages once the 
adult bees have clustered to maximize contact.   
 I chose to make my recommendation for treating package bees with OA based on 
the 6 day Varroa mite LD90 because the 3 day and 10 day time intervals are not realistic.  
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For example, bees must remain in their package for at least 3 days before they 
biologically become a swarm (personal observation).  In general, beekeepers do not 
install packages 3 days after they were created because of additional shipping transit 
time.  The 10 day time interval is also unrealistic because significant bee mortality occurs 
if packages are left caged for 10 days.  The 6 day time interval is the most realistic 
because it factors in the 3 days that are necessary for a package to become a swarm and it 
accounts for shipping transit time.   
My recommendation for treating packages with OA is based on achieving > 90% 
mite mortality and < 10% adult bee mortality as described below.  Table 4.2 indicates 
that the 6 day Varroa mite LD90 was 2.98 mL of a 2.8% OA solution per 1000 bees.  In 
addition, Table 4.3 indicates that there was no significant difference between the 
proportions of mites killed on package bees when volumes ≥ 3.1 mL per 1000 bees were 
applied (0.94 to 0.99).  From the mite mortality perspective, 3.0 mL per 1000 bees is the 
ideal volume to apply to packages.   
Table 4.4 indicates that volumes ≥ 4.6 mL per 1000 bees caused significant adult 
bee mortality when compared to untreated packages.  From the bee data perspective, 3 
mL per 1000 bees is the ideal volume because it does not cause significant bee mortality.  
The 3.1 mL per 1000 bee volume resulted in 10% greater bee mortality than untreated 
packages, however, the mortality was not significantly different from untreated packages 
(Table 4.4).  
The easiest method for preparing a 2.8% solution of OA is to mix 35 g OA 
dihydrate with 1 L of warm sugar water (Special Supplement 2005).  Although a 
pressurized air brush was used to apply small volumes of the OA solution in this study, 
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beekeepers may use a non-pressurized spray bottle to apply the OA.  Simply add the 
appropriate volume to the bottle and spray the adult bee cluster within the package until 
the solution is gone.  Another option for OA application is a MeterJet™ Spray Gun Kit.  
The MeterJet™ Spray Gun can be attached to a Solo®, D.B. Smith®, or SP Systems™ 
sprayer and delivers a precise metered volume of solution with each pull of the trigger.  
The MeterJet™ Spray Gun Kit can be purchased from various forestry supply companies 
such as Forestry Suppliers Inc.  (http://www.forestry-
suppliers.com/product_pages/View_Catalog_Page.asp?mi=1853)  (accessed January 1, 
2008).  
My recommendation for treating package bees is useful because it provides 
beekeepers and package bee shippers guidance for using OA to reduce mite populations 
from package bees or bulk bee boxes.  My data indicate that small deviations in the 
amount of OA applied to packages result in drastically different outcomes.  For example, 
although the 3.1 mL per 1000 bees volume did not cause significant bee mortality, the 4.6 
mL per 1000 bees volume caused significant bee mortality. Therefore, the applicator 
should emphasize accurate measurements when mixing and applying OA to package 
bees.   
 
 
  
Table 4.1 – Honey bee mortality responses to a 2.8% OA solution when sprayed on package bees.  
Honey bee 
mortality  n 
LD50 (95% CL)  
(mL per 1000 bees) 
LD15 (95% CL) 
(mL per 1000 bees) 
LD10 (95% CL) 
(mL per 1000 bees) 
3 d 162,934 7.97 (7.93 to 8.01) 3.80 (3.77 to 3.84) 2.60 (2.56 to 2.64) 
6 d 162,934 7.45 (7.41 to 7.48) 3.28 (3.24 to 3.31) 2.08 (2.04 to 2.12) 
    10 d 162,934 6.16 (6.13 to 6.19) 2.00 (1.96 to 2.03) 0.79 (0.75 to 0.84) 
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Table 4.2 – Varroa mite mortality responses to a 2.8% OA solution when sprayed on package bees.  
Mite 
mortality  n 
LD95 (95% CL) 
(mL per 1000 bees) 
LD90 (95% CL) 
(mL per 1000 bees) 
LD50 (95% CL) 
(mL per 1000 bees) 
3 d 9,309 3.83 (3.74 to 3.91) 3.25 (3.18 to 3.33) 1.57 (1.51 to 1.62) 
6 d 9,309 3.55 (3.47 to 3.64) 2.98 (2.91 to 3.05) 1.29 (1.23 to 1.35) 
    10 d 9,309 3.41 (3.32 to 3.49) 2.83 (2.76 to 2.90) 1.14 (1.08 to 1.20) 
83
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Table 4.3 – Estimates of the proportion of Varroa mites killed 
when package bees were sprayed with a 2.8% OA solution.  
Estimates with different letters indicate significant differences (t-
test, α = 0.05). 
Volume 
(mL per 1000 bees) Estimate ± Standard error n 
0.0 0.07 ± 0.04 a 36 
0.6 0.22 ± 0.07 b 36 
1.8 0.76 ± 0.07 c 36 
3.1 0.94 ± 0.04 d 42 
4.6 0.97 ± 0.03 d 36 
5.4 0.99 ± 0.02 d 36 
6.7 0.98 ± 0.03 d 30 
9.3 0.99 ± 0.02 d 39 
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Table 4.4 – Estimates of the proportion of honey bees killed when 
packages were sprayed with a 2.8% OA solution.  Estimates with 
different letters indicate significant differences (t-test, α = 0.05). 
Volume 
(mL per 1000 bees) Estimate ± Standard error n 
0.0 0.05 ± 0.04 a 36 
0.6 0.07 ± 0.04 a  36 
1.8 0.10 ± 0.05 ab 36 
3.1 0.15 ± 0.05 ab 42 
 4.6 0.22 ± 0.07 bc 36 
 5.4 0.21 ± 0.07 bc 36 
 6.7 0.35 ± 0.09 c 30 
 9.3 0.79 ± 0.06 d 39 
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Figure 4.1 – Rear view of package highlighting the sticky board compartment used to 
quantify mite mortality over time. 
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Figure 4.2 – Application of the OA solution using a pressurized airbrush.   
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Figure 4.3 – Left: The packages were chilled at 2°C for 20 minutes to force the bees 
to cluster.  Right: front view of the package highlighting the sliding screened side 
used to collect dead adult bees.   
 
  
Figure 4.4 – Varroa mite mortality response to a 2.8% OA solution when sprayed on package bees. 
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Figure 4.5 – Honey bee mortality response to a 2.8% OA solution when sprayed on package bees. 
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Chapter 5 
 
Oxalic acid – a prospective tool for reducing Varroa mite populations in package 
bees: Part II – Field evaluation 
 
Abstract 
 Results of research reported in chapter 4 were used to establish an optimum 
volume of a 2.8% oxalic acid (OA) solution to spray on package bees to reduce Varroa 
mite populations while minimizing adult bee mortality.  The two studies described in this 
chapter are field trials of package bee treatment protocols.  The first (preliminary study) 
was a feasibility study conducted prior to the laboratory studies reported in chapter 4.  
The second (secondary study) was conducted after the laboratory studies reported in 
chapter 4.  In both studies I made 2 lb Varroa-infested packages and treated them with 
OA prior to installation.  OA treatment significantly reduced Varroa infestation when 
compared to untreated packages, and OA’s efficacy was dependant on the concentration 
and volume applied.  The outcome of my research provides beekeepers and package bee 
shippers guidance for using OA to reduce mite populations in package bees. 
 
Introduction 
Numerous studies have investigated using oxalic acid (OA) to control Varroa 
mites in honey bee colonies.  In contrast, techniques for treating package bees with OA 
have not been previously investigated.  In chapter 4, I established an optimum volume of 
OA for spraying on package bees to provide effective mite control while minimizing 
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adult bee mortality (3.0 mL of a 2.8% OA sugar water solution (sugar:water) (1:1) (w:w) 
per 1000 bees).  I derived the optimum volume recommendation from a laboratory 
experiment where 97 cages containing approximately 1600 adult bees were treated with 
OA.  The two studies reported in this chapter (chapter 5) comprise the field component of 
my research on using OA to reduce Varroa mite populations in package bees.  My 
laboratory and field studies combine to provide package bee treatment recommendations 
that beekeepers or package bee shippers can safely use to reduce Varroa mites in package 
bees.   
The two experiments reported in this chapter are subsequently referred to as the 
preliminary study and the secondary study.  The preliminary study was conducted before 
the laboratory evaluation described in chapter 4.  At the time I conducted the preliminary 
study, European and Canadian recommendations for dissolving OA in sugar water to 
treat colonies were not established.  Most research reviewed by Nanetti et al. (2003) and 
Rademacher and Harz (2006) found that a single autumn trickle treatment with 50 mL of 
a 3.0% OA sugar water solution (1:1) (w:w) provided an efficacy of greater than 90% in 
Central Europe.  For my preliminary study, I chose a conservative concentration and 
volume of OA for package bee treatment to minimize the risk of adult bee mortality.  I 
chose to apply 25 mL of a 2.0% OA sugar water solution (sugar:water) (1:1) (w:w) per 2 
lb package to approximate a dose that was less than the 48 hour LD10 for adult honey 
bees (equivalent to 3.9 mL per 1000 bees) reported in chapter 1.  The results of the 
preliminary study, 62.5 ± 15.8% Varroa infestation reduction, led me to conduct the 
laboratory studies (chapter 4) and subsequent secondary study to find the optimum 
volume and concentration of OA to apply to package bees. 
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At the time the secondary study was conducted, the Canadian Honey Council had 
provided the American Beekeeping Federation their OA registration data packet to 
expedite its registration in the United States.  As a result, the recommended concentration 
of the OA solution that will appear on the United States label will most likely be identical 
to the Canadian label.  Therefore, I used a concentration of OA for the secondary study 
that was based on the Canadian treatment recommendations for honey bee colonies.  The 
Canadian label recommends dissolving 35 g of OA dihydrate in 1 L of warm syrup made 
from a mixture of sugar and water (sugar:water) (1:1) (weight:volume) (Special 
Supplement 2005).  This mixture results in a 2.8% OA sugar water solution by weight 
(sugar:water) (1:1) (w:w).  I used my results from chapter 4 regarding the volume of a 
2.8% OA solution to apply to packages for > 90% mite control and no significant bee 
mortality.  The goal of the secondary study was to verify the laboratory-based protocol 
for treating package bees with OA to reduce Varroa populations.  The end product would 
be a field-tested recommendation for treating package bees or bulk bee boxes that would 
be useful to beekeepers and package bee shippers. 
 
Materials and Methods 
Preliminary study 
Stocking of packages 
I shook 18 kg of Varroa-infested adult honey bees from 12 source colonies into a 
bulk bee box on the evening of May 15th, 2005.  The source colonies were located at the 
University of Nebraska-Lincoln’s Agricultural Research and Development Center 
(ARDC) near Mead, NE.  I had previously caged the queens from the source colonies to 
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ensure that all mites were phoretic on adult bees (April 25).  The source colonies were 2 
stories high and were composed of a mixture of Italian and Carniolan bees.  I added 1 
frame of honey, 2 frames of pollen and nectar, 1 frame of unsealed brood, and 1 frame 
with 20 caged queens to stabilize the bulk bee box.  In addition, I fit the bulk bee box 
with top feeders that contained 6 L of light syrup (sugar:water) (1:1) (w:w) and 3 L of 
water.  I maintained the bees in the bulk box overnight to allow the bees to cluster and the 
mite population to become equally distributed.   
The next day, I made 19 packages of adult bees by subdividing the adult bee 
population in the bulk bee box (May 16).  The package cages were standard, 2 lb cages 
made of pine wood and 8-mesh hardware cloth.  They contained a caged queen and a 
feeder can containing light syrup (sugar:water) (1:1) (w:w).  The average weight of the 
adult bees in 8 randomly chosen packages was 1.9 ± 0.2 lbs (0.8 ± 0.1 kg).  After 
transferring bees from the bulk cage to individual packages, I held them in a dark, cool 
warehouse for 72 hours.   
 
Establishing the volume of OA to apply to the packages 
I used the bioassay data from chapter 1 to determine a conservative dose of OA to 
apply to the packages without injuring adult bees.  The bioassay data estimated the 48 
hour LD10 for adult honey bees to be 177 µg per bee (95% CL = 120 to 226 µg per bee) 
(Table 1.1).  I picked a volume of 25 mL of a 2.0% OA sugar water solution 
(sugar:water) (1:1) (w:w) per package to approximate a dose that was less than the 48 
hour LD10 for adult honey bees (equivalent to 3.9 mL per 1000 bees).  A volume greater 
than 25 mL may have resulted in the premature death of packages.  My calculations were 
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as follows: 25 g of OA in 1 L of sugar water results in approximately 0.025 g OA/mL 
solution (2.0% OA sugar water solution).  25 mL of OA solution X 0.025 g OA/mL 
solution = 0.625 g OA per package (625,000 µg per package).  625,000 µg per package / 
6500 bees per package = 96 µg per bee.   
 
Treatment and data collection 
 I randomly assigned the 19 packages to 2 treatment groups: 1.) untreated and 2.) 
OA treatment.  I prepared a 2.0% solution of OA by mixing 25 g OA with 1 L of sugar 
water (sugar:water) (1:1) (w:w).  I administered the treatments by spraying 25 mL of the 
OA solution directly on the bees through the mesh screen cage using a non-pressurized 
sprayer (spray bottle) 72 hours after the packages were made.  I measured 25 mL of the 
OA solution in a graduated cylinder, poured the liquid into the spray bottle, and sprayed 
the adult bee cluster until the solution was gone.  I made an effort to maximize OA 
contact with the adult bees by spraying both sides of the screen cages.  I sprayed the 
untreated group with 25 mL of sugar water (sugar:water) (1:1) (w:w). 
 I installed the packages in single-story Langstroth beehives (24.4 cm deep hive 
body) approximately 8 hours after treatment in an apiary near Lincoln, NE.  I furnished 
each hive with 8 empty frames with foundation and a division board feeder containing 1 
gallon of syrup (sugar:water) (2:1) (w:w).  The entrances to the hives were reduced to 
approximately 2.5 cm to reduce drifting and discourage robbing behavior.  As the 
experiment progressed over a 7 week period, the hives were provided with a queen 
excluder and 1 or 2 supers (16.8 cm deep) as needed.      
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I collected 8 samples of approximately 300 adult bees in alcohol from the bulk 
bee box while stocking the packages to estimate the pre-treatment Varroa infestation 
level on adult bees.  I also collected approximately 300 adult bees in alcohol 1 and 3 
weeks after package installation to estimate the post-treatment Varroa infestation level on 
adult bees.  I estimated the pre- and post-treatment Varroa infestation levels using the 
alcohol wash method (Shimanuki and Knox 2000).  All mites were phoretic on adult bees 
1 week after package installation because appropriately aged brood for mite invasion was 
not yet present in the hives.  In contrast, the hives had brood of all ages (eggs, larvae, and 
pupae) 3 weeks after package installation.  I measured the square inches of capped 
worker brood and counted the number of frames that the adult bee cluster occupied 3 and 
6 weeks after package installation.  I weighed the hives at the end of the study to quantify 
the impact of OA treatment on weight gain (7 weeks after package installation). 
 
Experimental design and statistical analysis 
 I designed my experiment as a completely randomized design (CRD).  I used 
mites-per-100 adult bees 1 and 3 weeks after package installation, the percentage 
reduction in Varroa infestation 1 and 3 weeks after package installation, the number of 
frames of adult bees in each hive 3 and 6 weeks after package installation, the square 
inches of capped worker brood 3 and 6 weeks after package installation, and the average 
weight-per-hive 7 weeks after package installation as response variables. 
I analyzed the mites-per-100 adult bees data, the percentage reduction in Varroa 
infestation data, the number of frames of adult bees data, and the square inches of capped 
worker brood data using PROC GLIMMIX (SAS Institute 2006) and separated means 
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using a t-test (α = 0.05).  I fit a generalized linear model (GLM) for each of the 
aforementioned response variables using a normal distribution except for the number of 
frames of adult bees data.  This data set differed from the other response variables 
because the data were frame counts (1 to 9 frames).  For this response variable, I fit a 
GLM and implemented the Poisson distribution in PROC GLIMMIX.  
I framed my data as a factorial with time and treatment as factors.  Time had 2 
levels: 1 and 3 weeks (or 3 and 6 weeks depending on the response variable).  Treatment 
had 2 levels: untreated and OA treatment.  I applied the ‘group=trt’ option in PROC 
GLIMMIX to fit a separate variance for the 2 treatment levels.  I used PROC 
UNIVARIATE (SAS Institute 2006) to verify my assumptions of normality and equal 
variance (except for the number of frames data as this distribution was Poisson).   
I also analyzed the average weight-per-hive data using PROC GLIMMIX (SAS 
Institute 2006) and separated means using a t-test (α = 0.05).  This data set differed from 
the abovementioned because it was not a factorial.  It was a CRD with two treatments: 
untreated and OA treatment.  
 
Secondary study 
 The materials and methods that I used for the secondary study were identical to 
those described for the preliminary study except for the differences listed below: 
1. Stocking of packages 
a. I shook 29 kg of Varroa-infested adult honey bees from 20 source colonies 
into a bulk bee box in September 2006. 
 
 98
  
b. I made 31 packages of adult bees by subdividing the adult bee population in 
the bulk bee box.  Each package was placed on a scale and the scale was 
tared.  I then stocked the package with adult bees until it weighed 2 lbs.  The 
average weight of the adult bees present in the packages was 2.0 ± 0.1 lbs (0.9 
± 0.03 kg) (n = 31). 
2. Establishing the volume of OA to apply to the packages 
a. I used my recommendation from chapter 4 regarding the optimum dosage of 
OA to apply to packages for > 90% mite control and no significant bee 
mortality. 
i. The recommended volume that I applied was 3.0 mL of a 2.8% OA 
sugar water solution (sugar:water) (1:1) (w:w) per 1000 bees. 
ii. I also included a slightly higher dose to monitor the effects on adult 
honey bees (4.5 mL of a 2.8% OA sugar water solution (sugar:water) 
(1:1) (w:w) per 1000 bees).  I chose this dose to assess the risk 
associated with over-application.   
3. Treatment and data collection 
a. I treated the packages the same day that they were stocked with bees. 
b. The experiment was terminated 8 days after package installation. 
c. I prepared a 2.8% solution of OA by mixing 35 g OA with 1 L of sugar water 
(sugar:water) (1:1) (w:w).   
d. I administered the treatments using a Solo® backpack sprayer with a 3 gallon 
chemical tank and piston pump system.  I furnished the sprayer with a 
MeterJet™ spray gun.  The spray gun was calibrated to deliver either 7.0 or 
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10.5 mL of OA solution with each pull of the trigger depending on the 
treatment.   
i. Three pulls of the trigger with the MeterJet™ spray gun calibrated to 
deliver 7.0 mL per pull resulted in 21.0 mL per package (3.0 mL per 
1000 bees treatment). 
ii. Three pulls of the trigger with the MeterJet™ spray gun calibrated to 
deliver 10.5 mL per pull resulted in 31.5 mL per package (4.5 mL per 
1000 bees treatment). 
e. I collected 10 samples of approximately 300 adult bees in alcohol from the 
bulk bee box while stocking the packages to estimate the pre-treatment 
Varroa infestation level on adult bees.   
4. Experimental design and statistical analysis 
a. I did not measure the square inches of capped worker brood or weigh the 
hives. 
b. I used mites-per-100 adult bees 8 days after package installation, the 
percentage reduction in Varroa infestation 8 days after package installation, 
and the number of frames of adult bees 8 days after package installation as 
response variables.   
c. I analyzed the mites-per-100 adult bees data, the percentage reduction in 
Varroa infestation data, and the number of frames of adult bees data using 
PROC GLIMMIX (SAS Institute 2006), and I separated means using a t-test 
(α = 0.05).  I fit a GLM for each of the aforementioned response variables 
using a normal distribution except for the number of frames of adult bees 
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data.  This data set differed from the other response variables because the data 
were frame counts (1 to 9 frames).  For this response variable, I fit a GLM 
and implemented the Poisson distribution in PROC GLIMMIX.  
i. The mites-per-100 adult bees data were designed as a CRD with 4 
treatments: 1.) bulk bee box pre-treatment, 2.) untreated, 3.) 3.0 mL per 
1000 bees OA solution, and 4.) 4.5 mL per 1000 bees OA solution.   
ii. The percentage reduction in Varroa infestation data and the number of 
frames of adult bees data were designed as CRD’s with 3 treatments: 1.) 
untreated, 2.) 3.0 mL per 1000 bees OA solution, and 3.) 4.5 mL per 
1000 bees OA solution. 
 
Results 
Preliminary study 
My assumption of normality was met for all response variables for which I fit a 
GLM using a normal distribution.  These data sets produced a symmetric box-plot and a 
straight-lined normal probability plot that confirmed normality.  A plot of the residual 
versus the predicted values revealed a problem with non-constant variance.  The 
‘group=trt’ option that I employed in PROC GLIMMIX fixed the non-constant variance 
issue.  After fitting a separate variance for each treatment, a plot of the residual versus the 
predicted values revealed no obvious patterns and was indicative of data that had constant 
variance.   
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Treatment*time factorial with mites-per-100 adult bees as the response variable 
 I modeled the factors treatment, time, and the treatment*time interaction.  The 
treatment*time interaction was significant (F = 7.65, df = 1, 34, P = 0.0091), and 
therefore, the simple effects of treatment and time were considered.   See Table 5.1 for 
the treatment estimates of mites-per-100 adult bees 1 and 3 weeks after package 
installation.  One week after package installation, hives established from the OA-treated 
packages had 5.1 ± 1.7 fewer mites-per-100 bees than hives established from the 
untreated packages (t = 3.08, df = 34, P = 0.0041).  In contrast, there was no significant 
difference in Varroa infestation between hives established from OA-treated packages and 
hives established from untreated packages 3 weeks after package installation (t = 0.84, df 
= 34, P = 0.4059).   When only considering the untreated packages, there were 6.9 ± 1.4 
more mites-per-100 bees 1 week after package installation than 3 weeks after package 
installation (t = 5.58, df = 34, P = 0.0001).  Similarly, when only considering the OA-
treated packages, there were 2.2 ± 1.2 more mites-per-100 bees 1 week after package 
installation than 3 weeks after package installation (t = 1.87, df = 34, P = 0.0501).    
 The Varroa infestation in the bulk bee box was not significantly different than the 
Varroa infestation in the hives established from untreated packages 1 week post-
treatment (t = 0.30, df = 15, P = 0.7693). 
 
Treatment*time factorial with percentage reduction in Varroa infestation as the response 
variable 
 
 I modeled the factors treatment, time, and the treatment*time interaction.  The 
treatment*time interaction was significant (F = 7.59, df = 1, 34, P = 0.0094), and 
therefore, the simple effects of treatment and time were considered.   See Table 5.2 for 
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the treatment estimates of the percentage reduction in Varroa infestation 1 and 3 weeks 
after package installation.  One week after package installation, OA treatment 
significantly reduced Varroa infestation by 70.6 ± 23.0% when compared to hives 
established from the untreated packages (t = 3.07, df = 34, P = 0.0042).  In contrast, there 
was no significant difference in Varroa infestation between hives established from OA-
treated packages and hives established from untreated packages 3 weeks after package 
installation (t = 0.85, df = 34, P = 0.4008).  When only considering the untreated 
packages, the 3 week Varroa infestation diminished 96.1 ± 17.2% compared to the 
Varroa infestation 1 week after package installation (t = 5.58, df = 34, P = 0.0001).  
Similarly, when only considering the OA-treated packages, the 3 week Varroa infestation 
diminished 30.7 ± 16.3% compared to the Varroa infestation 1 week after package 
installation (t = 1.88, df = 34, P = 0.0503).   
 
Treatment*time factorial with the number of frames of adult bees as the response 
variable 
 
 I modeled the factors treatment, time, and the treatment*time interaction.  The 
treatment*time interaction was not significant (F = 0.12, df = 1, 34, P = 0.7356), and 
therefore, the main effects of treatment and time were considered.  The treatment effect 
was not significant (F = 0.06, df = 1, 34, P = 0.8096).  The time effect was significant (F 
= 11.00, df = 1, 34, P = 0.0022).  See Table 5.3 for the treatment estimates of the number 
of frames of adult bees 3 and 6 weeks after package installation.   
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Treatment*time factorial with the square inches of capped worker brood as the response 
variable 
 
 I modeled the factors treatment, time, and the treatment*time interaction.  The 
treatment*time interaction was not significant (F = 0.01, df = 1, 34, P = 0.9071), and 
therefore, the main effects of treatment and time were considered.  The treatment effect 
was not significant (F = 0.01, df = 1, 34, P = 0.9321).  The time effect was also not 
significant (F = 1.26, df = 1, 34, P = 0.2702).  See Table 5.4 for the treatment estimates 
of the square inches of capped worker brood 3 and 6 weeks after package installation.   
 
CRD with the weight-per-hive (lbs) 7 weeks after package installation as the response 
variable 
 
 The treatment effect was not significant (F = 1.53, df = 1, 17, P = 0.2334).  See 
Table 5.5 for the treatment estimates of the weight-per-hive 7 weeks after package 
installation.   
 
Secondary study 
My assumption of normality was met for the 2 response variables for which I fit a 
GLM using a normal distribution.  These data sets produced a symmetric box-plot and a 
straight-lined normal probability plot that confirmed normality.  A plot of the residual 
versus the predicted values revealed a problem with non-constant variance.  The 
‘group=trt’ option that I employed in PROC GLIMMIX fixed the non-constant variance 
issue.  After fitting a separate variance for each treatment, a plot of the residual versus the 
predicted values revealed no obvious patterns and was indicative of data that had constant 
variance.   
 
 104
  
CRD with mites-per-100 adult bees 8 days after package installation as the response 
variable 
 
The treatment effect was significant (F = 121.86, df = 3, 37, P = 0.0001).  See 
Table 5.6 for the treatment estimates of mites-per-100 adult bees 8 days after package 
installation.  Colonies established from the untreated packages had 2.2 ± 0.9 more mites-
per-100 bees than the bulk bee box (t = 2.36, df = 37, P = 0.0237).  Colonies established 
from the packages treated with the low OA volume (3.0 mL per 1000 bees) had 7.7 ± 0.7 
fewer mites-per-100 bees than the bulk bee box (t = 10.44, df = 37, P = 0.0001).  
Similarly, colonies established from the packages treated with the high OA volume (4.5 
mL per 1000 bees) had 7.6 ± 0.8 fewer mites-per-100 bees than the bulk bee box (t = 
10.06, df = 37, P = 0.0001).  Colonies established from the packages treated with the low 
OA volume had 9.9 ± 0.6 fewer mites-per-100 bees than the untreated packages (t = 
16.25, df = 37, P = 0.0001).  Likewise, colonies established from the packages treated 
with the high OA volume had 9.7 ± 0.6 fewer mites-per-100 bees than the untreated 
packages (t = 15.61, df = 37, P = 0.0001).  There was no significant difference in Varroa 
infestation between colonies established from the packages that were treated with the low 
OA volume and the packages that were treated with the high OA volume (t = 0.50, df = 
37, P = 0.6178).   
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CRD with the percentage reduction in Varroa infestation 8 days after package 
installation as the response variable 
 
The treatment effect was significant (F = 136.95, df = 2, 28, P = 0.0001).  See 
Table 5.7 for the treatment estimates of the percentage reduction in Varroa infestation 8 
days after package installation.  Colonies established from the packages treated with the 
low OA volume (3.0 mL per 1000 bees) had 104.5 ± 6.4% fewer mites than the colonies 
established from the untreated packages (t = 16.25, df = 28, P = 0.0001).  Colonies 
established from the packages treated with the high OA volume (4.5 mL per 1000 bees) 
had 102.8 ± 6.6% fewer mites than the colonies established from the untreated packages 
(t = 15.59, df = 28, P = 0.0001).  There was no significant difference in Varroa 
infestation between colonies established from the packages that were treated with the low 
OA volume and the packages that were treated with the high OA volume (t = 0.48, df = 
28, P = 0.6349).   
 
CRD with the number of frames of adult bees 8 days after package installation as the 
response variable 
 
The treatment effect was not significant (F = 0.08, df = 2, 28, P = 0.9278).  See 
Table 5.8 for the treatment estimates of the number of frames of adult bees in hives 8 
days after package installation.   
 
Discussion 
Preliminary study 
Oxalic acid treatment significantly reduced Varroa infestation by 71% when 
compared to hives stocked with untreated packages one week after installation.  Although 
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this statistic is encouraging, the standard error of the estimate was ± 23%.  As a result, the 
efficacy of OA was highly variable and unreliable.  An explanation for the high variance 
in efficacy is that the packages may have received different volumes of the OA solution.  
It was impossible to deliver exactly 25 mL of the OA solution per package with a non-
pressurized spray bottle.  Furthermore, I only weighed a subsample of the packages to 
estimate the number of adult bees present, resulting in variable dosages.  I addressed both 
of these issues in the secondary study by using a MeterJet™ spray gun to accurately 
apply the OA solution and by weighing each package prior to treatment. 
Another drawback of the preliminary study is that I treated the packages the same 
day that I installed them.  This may have reduced the efficacy of OA against mites 
because the length of OA exposure before installation was brief.  In contrast, I maximized 
exposure time by treating the packages the same day they were made for the secondary 
study.  This ensured that mites would be exposed to OA for at least 72 h before 
installation in hives.  
Despite OA’s variable efficacy when applied to package bees in the preliminary 
study, treatment did not negatively affect the adult bee population, the amount of capped 
worker brood, or the hive weight at the end of the study.  Furthermore, all hives remained 
queenright throughout experimentation.   
I designed the preliminary experiment so that all mites would be phoretic on adult 
bees 1 week after package installation.  This ensured that the 1 week post-treatment 
sample would provide an accurate comparison between the Varroa infestation in the bulk 
bee box and the Varroa population in each hive.  Furthermore, the 1 week post-treatment 
sample verified that the Varroa infestation in the bulk bee box (7.3 ± 1.0 mites-per-100 
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bees) was not significantly different than the Varroa infestation in the hives established 
from untreated packages (7.8 ± 1.2 mites-per-100 bees).  This confirmed that mites had 
not invaded brood and that my experimental protocol regarding the use of the bulk bee 
box as a pre-treatment estimate of Varroa infestation was justified.   
I predicted that the hives would have brood of all ages (eggs, larvae, and pupae) 3 
weeks after package installation because the packages were installed with healthy, mated 
queens.  An interesting result from the preliminary study was that the Varroa infestation 
on adult bees significantly declined in all experimental hives 3 weeks after package 
installation, regardless of treatment (Tables 5.1 and 5.2).  This statistic indicates that 
mites readily invade appropriately aged brood to begin reproduction in hives started from 
package bees, and highlights the importance of reducing Varroa populations in packages 
prior to installation.  
 
Secondary study   
 An unexpected result from the secondary study was that although no Varroa 
reproduction could have occurred, the Varroa infestation in hives established from the 
untreated packages significantly increased 8 days after package installation (Table 5.6).  
This observation can be explained by the presence of robbing bees during the installation 
process.  Upon reaching the apiary, the packages were immediately inundated with bees 
from an unknown source.  The packages had a single layer of bees clinging to the outside 
of the cages.  I quickly installed the packages because daylight was running out and the 
bees had consumed most of the syrup in their feed cans.  I released the queens and sealed 
the hive entrances to ensure no additional bees could invade the hives.  Despite my 
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efforts, some foreign bees entered each hive during installation.  The next morning, 
robbing bees were no longer a problem and I opened each hive entrance approximately 
1.3 cm to allow the bees to fly. 
 I terminated the secondary study after collecting the samples of adult bees 8 days 
after package installation.  Although each hive had approximately 2 frames of adult bees, 
all hives were queenless.  I found 3 dead queens inside of their hives that had battered 
wings and were stripped of body hair.  The robbing bees must have balled the queens 
while the package bees were still wet from the installation process.  In hindsight, I should 
have left the queens in their cages overnight instead of releasing them into the hives when 
foreign bees were present.  Regardless, the secondary study provides evidence that 
invading bees that drift into or rob a hive have the potential to significantly increase the 
Varroa infestation.  
 It is interesting that the colonies established from the packages treated with the 
low or high volume of OA had approximately 100% fewer mites than the colonies 
established from the untreated packages (remember that percentage reduction in Varroa 
infestation was calculated using the bulk bee box as the pre-treatment sample).  This 
makes sense considering that the untreated packages increased in Varroa infestation by 
about 20% and the treated packages had about an 80% reduction in Varroa infestation  
(80% reduction in treated hives compared to a 20% increase in untreated hives = 100% 
reduction in Varroa infestation).  My results suggest that the treated packages were 
nearly devoid of Varroa mites prior to installation, and like the untreated packages, 
acquired mites due to the invasion of foreign, mite-infested bees.      
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The secondary study was conducted in the fall (September) when strong colonies 
are prone to attempt to rob small or weak colonies.  I did not anticipate robber bees 
because there were no other apiaries in the vicinity, suggesting that the robbing bees 
originated from feral colonies or a distant apiary.  In reality, beekeepers in temperate 
climates normally install package bees in the spring when robbing is less likely to occur.   
The problem that occurred with robbing bees in the secondary study caused me to 
prematurely terminate the experiment.  As a result, it was impossible to collect the same 
type of data reported in the preliminary study (3 week adult bee samples, square inches of 
capped worker brood, hive weight, and queen survival).  Consequently, the data gathered 
from the secondary study will not be submitted for publication in a scientific journal, but 
was included in the dissertation for completeness.  
 
Overall conclusions 
The use of the MeterJet™ for OA application was quick, easy, and accurate.  If 
beekeepers use my recommendation for treating package bees described in chapter 4, I 
strongly suggest the employment of a MeterJet™ spray gun used in conjunction with a 
backpack sprayer.  Chapters 4 and 5 provide strong evidence that deviations in both the 
concentration and volume of the OA solution applied will significantly affect efficacy 
and adult bee tolerance.  Also, it is important to weigh each package, cage, or bulk bee 
box before OA treatment to accurately calculate the volume of OA to apply.  The 
applicator should emphasize accurate measurements when mixing and applying OA to 
package bees to maximize efficacy and minimize adult bee injury.   
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My chapter 4 results support applying an optimum volume of 3.0 mL of a 2.8% 
OA solution per 1000 bees for effective mite control with minimal adult bee mortality.  
The outcome of my field trials suggests that OA can be used safely to reduce mites in 
package bees, however, the study should be repeated due to the problem that occurred 
with robbing bees during installation.   
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Table 5.1 – Preliminary study.  Treatment estimates with 
mites-per-100 adult bees 1 and 3 weeks after package 
installation as the response variable.  Estimates with different 
letters indicate significant differences (t-test, α = 0.05). 
Treatment* Estimate ± Standard error n 
 1 week-untreated  7.8 ± 1.2 a  9 
 1 week-OA 2.0%**  2.7 ± 1.1 b  10 
 3 week-untreated  0.9 ± 0.3 c  9 
 3 week-OA 2.0%**  0.5 ± 0.3 c  10 
* The Varroa infestation in the bulk bee box was 7.3 ± 1.0 (n=8) 
mites-per-100 bees. 
** The packages were sprayed with 3.9 mL per 1000 bees of a 2.0% 
OA sugar water solution by weight (sugar:water) (1:1) (w:w).   
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Table 5.2 – Preliminary study.  Treatment estimates with percentage 
reduction in Varroa infestation 1 and 3 weeks after package 
installation as the response variable.  Estimates with different letters 
indicate significant differences (t-test, α = 0.05). 
Treatment Estimate ± Standard error* n 
 1 week-untreated  -8.0 ± 16.7 a 9 
 1 week-OA 2.0%**  62.5 ± 15.8 b 10 
 3 week-untreated  88.1 ± 4.4 c 9 
 3 week-OA 2.0%**  93.2 ± 4.1 c 10 
* Percentage reduction in Varroa infestation was calculated using the 
mite infestation in the bulk bee box as the pre-treatment baseline 
(7.3 ± 1.0 mites-per-100 bees). 
** The packages were sprayed with 3.9 mL per 1000 bees of a 2.0% 
OA sugar water solution by weight (sugar:water) (1:1) (w:w).   
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Table 5.3 – Preliminary study.  Average number of frames of adult 
bees in hives 3 and 6 weeks after package installation.  Estimates 
with different letters indicate significant differences (t-test, α = 0.05). 
Treatment Estimate ± Standard error n 
 3 week-untreated  3.3 ± 0.6 a 9 
 3 week-OA 2.0%*  3.7 ± 0.6 a  10 
 6 week-untreated  5.9 ± 0.8 b  9 
 6 week-OA 2.0%*  5.8 ± 0.8 b 10 
* The packages were sprayed with 3.9 mL per 1000 bees of a 2.0% 
OA sugar water solution by weight (sugar:water) (1:1) (w:w).   
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Table 5.4 – Preliminary study.  Average square inches of capped 
worker brood in hives 3 and 6 weeks after package installation.  
Estimates with different letters indicate significant differences (t-test, 
α = 0.05). 
Treatment Estimate ± Standard error n 
 3 week-untreated  282.0 ± 48.8 a 9 
 3 week-OA 2.0%*  272.9 ± 40.8 a  10 
 6 week-untreated  226.4 ± 48.8 a   9 
 6 week-OA 2.0%*  227.8 ± 40.8 a  10 
* The packages were sprayed with 3.9 mL per 1000 bees of a 2.0% 
OA sugar water solution by weight (sugar:water) (1:1) (w:w).   
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Table 5.5 – Preliminary study.  Average weight-per-hive 7 weeks after 
package installation.  Estimates with different letters indicate significant 
differences (t-test, α = 0.05). 
Treatment Estimate (lbs) ± Standard error n 
Untreated  91.3 ± 5.0 a 9 
OA 2.0%*  82.9 ± 4.7 a  10 
* The packages were sprayed with 3.9 mL per 1000 bees of a 2.0% 
OA sugar water solution by weight (sugar:water) (1:1) (w:w).   
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Table 5.6 – Secondary study.  Treatment estimates with mites-per-
100 adult bees 8 days after package installation as the response 
variable.  Estimates with different letters indicate significant 
differences (t-test, α = 0.05). 
Treatment Estimate ± Standard error n 
Bulk bee box*  9.4 ± 0.7 a  10 
Untreated  11.6 ± 0.6 b  10 
3.0 mL per 1000 bees**  1.7 ± 0.2 c  11 
4.5 mL per 1000 bees**  1.9 ± 0.2 c  10 
* The bulk bee box estimate represents the pre-treatment baseline for 
Varroa infestation as the samples were obtained as the packages 
were made.  
** The packages were sprayed with a 2.8% OA sugar water solution 
by weight (sugar:water) (1:1) (w:w). 
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Table 5.7 – Secondary study.  Treatment estimates with percentage 
reduction in Varroa infestation 8 days after package installation as 
the response variable.  Estimates with different letters indicate 
significant differences (t-test, α = 0.05). 
Treatment Estimate ± Standard error* n 
Untreated  -22.5 ± 6.0 a  10 
3.0 mL per 1000 bees**  81.9 ± 2.2 b  11 
4.5 mL per 1000 bees**  80.3 ± 2.6 b  10 
* Percentage reduction in Varroa infestation was calculated using the 
mite infestation in the bulk bee box as the pre-treatment baseline 
(9.4 ± 0.7 mites-per-100 bees). 
** The packages were sprayed with a 2.8% OA sugar water solution 
by weight (sugar:water) (1:1) (w:w). 
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Table 5.8 – Secondary study.  Average number of frames of adult bees 
in hives 8 days after package installation.  Estimates with different 
letters indicate significant differences (t-test, α = 0.05). 
Treatment Estimate ± Standard error n 
Untreated  1.9 ± 0.2 a  10 
3.0 mL per 1000 bees*  1.8 ± 0.3 a  11 
4.5 mL per 1000 bees*  2.0 ± 0.2 a  10 
* The packages were sprayed with a 2.8% OA sugar water solution 
by weight (sugar:water) (1:1) (w:w). 
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Chapter 6 
  
Bee-to-bee contact drives oxalic acid distribution in honey bee colonies 
 
Abstract 
I constructed 10 divided hives to study the distribution of oxalic acid (OA).  I split 
experimental colonies into 2 equal sections with 1 of 3 divider types.  The first divider 
allowed trophallaxis to occur between adult bees on each side, but did not allow physical 
contact.  The second divider did not allow trophallaxis or physical contact.  The third 
divider allowed both physical contact and trophallaxis between the 2 sides.  All 3 dividers 
allowed gas exchange of volatile materials.  The objective was to investigate factors that 
contribute to the distribution of OA in a hive by monitoring Varroa mortality.  I trickled 
40 mL of a 3.5% OA sugar water solution on one side of the divider.  I used sticky boards 
to quantify mite fall before, during, and after OA treatment on both treated and untreated 
sides.  Trophallactic interactions and fumigation did not significantly influence the 
distribution of OA.  Bee-to-bee contact was the primary route for OA distribution.  
 
Introduction 
The bioassay data from chapter 1 indicate that OA has a high acute toxicity to 
Varroa mites.  I hypothesize that OA may kill Varroa mites via contact.  The 24 hour 
LC50 (95% CL) for phoretic Varroa mites was 5.12 (3.5 to 7.0) μg of OA per 20-mL vial.  
The toxicity of OA to Varroa mites collected from bee brood was quantified by Milani 
(2001) who reported that the 24 hour LD50 (95% CL) (median lethal density) for Varroa 
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mites collected from brood was 1.9 (1.49 to 2.36) μg/cm2.  My bioassay results from 
chapter 1 and results from Milani (2001) suggest that OA has a high acute toxicity to 
mites.  The high acute toxicity of OA to Varroa mites in glass-vial residual bioassays 
suggests that OA readily kills mites that come in physical contact with the crystals 
although some mite mortality could have been caused by exposure to OA vapors within 
the scintillation vials.   
The objective of the current study was to identify factors that contribute to the 
distribution of OA in a hive and to test my hypothesis that OA kills mites via contact.  I 
evaluated the importance of fumigation, trophallaxis, and direct contact when trickling 
OA.  The results will give beekeepers and researchers insight as to how OA is distributed 
in hives.  My results will provide guidance for selecting application techniques that 
maximize the efficacy of OA.   
 
Materials and Methods 
Construction of divided (split-unit) hives  
 I designed and built 10 divided single-story Langstroth hives in June, 2005.  My 
hives resembled standard, single story Langstroth beehives.  I modified the boxes by 
splitting them into 2 equal sections that held 4 frames each (Figure 6.1).  I separated the 
sections using 1 of 3 different dividers.  All dividers had a 2 X 46.5 cm wooden frame 
that formed bee-tight seals between the sides of the hive body, the inner cover, and the 
bottom board.  The first divider (single-screen divider) had a 585 cm2 area in its center 
made from 8-mesh screen and it allowed trophallaxis and gas exchange between bees on 
the 2 sides.  The second divider (double-screen divider) had a 585 cm2 area in its center 
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made from 2 pieces of 8-mesh screen that were separated by a 2 cm gap.  It allowed gas 
exchange, but did not allow trophallaxis between the 2 sides.  The third divider (queen 
excluder divider) had a 585 cm2 area in its center made from plastic queen excluder that 
allowed worker bees to move freely between the 2 sides.  It allowed trophallaxis, gas 
exchange, and physical contact between the 2 sides.  The 3 dividers described above are 
shown in Figure 6.2.  The fourth divider was a solid-wood divider that did not allow adult 
bee interaction or gas exchange between the 2 sides.  
 All divided colonies had a separate entrance for each side.   The entrances faced 
opposing directions to minimize the drift of adult bees from side-to-side.  In addition, the 
bottom board was fitted with 8-mesh screen that allowed mites to fall onto a sticky board 
placed below the screen.  This allowed me to independently monitor mite fall on each 
side of the divider (Figure 6.1).   
 I designed the divided hives to allow me to examine the distribution of OA by 
treating one side and monitoring the resulting mite fall in both the treated and untreated 
sections.  I expected similar mite fall on the sides that were treated with OA regardless of 
divider.  My intention was to correlate mite fall on the untreated section with divider 
type.  The design of my dividers allowed me to restrict the amount of adult bee 
interaction between each half-unit and ranged from complete isolation (solid divider) to 
minimal isolation (queen excluder divider) as described above.  
 
Stocking of hives  
 I stocked the 10 divided hives by splitting Varroa-infested colonies from an 
apiary located at the University of Nebraska Agricultural Research and Development 
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Center on June 29, 2005.  The apiary was composed of a mixture of Carniolan and Italian 
honey bees (Apis mellifera).  At this time, all hives were given a solid-wood divider.  I 
furnished each side of the divided hive with a frame of capped brood, a frame of honey, a 
frame of pollen, and an empty frame with foundation.  This resulted in 4 frames for each 
side and 8 frames for the entire divided Langstroth hive.  I transferred adult bees to the 
units directly on the combs from which the splits were made.  I immediately sealed the 
hives and moved them approximately 35 miles to the University of Nebraska-Lincoln 
East Campus.  I placed a 15 day old queen cell in each side of the divided colonies the 
following day (June 30).  I left the hives untouched for approximately 2 weeks.  This 
period allowed mites to emerge from brood cells and gave the virgin queens time to mate 
and begin laying eggs.   
 I randomly assigned 9 of the 10 hives to 3 treatment groups.  I assigned 3 hives to 
each of 3 treatment groups (single-screen divider, double-screen divider, and queen 
excluder divider).  I removed the solid-wood dividers that I used when the units were 
stocked and replaced them with the appropriate dividers listed above.  I also verified that 
each side of the divided colony was queenright and that sealed brood was not present.  I 
only included divided hives that had successfully reared a queen on each side in this 
experiment.  I used queen cells to make each side queenright resulting in hives void of 
capped brood during treatment.  This ensured that all mites present in the hives were 
phoretic on adult bees and vulnerable to OA treatment.   
 I left the remaining 10th hive untouched with its solid-wood divider in place.  I did 
not include the solid-wood divider hive in the statistical analysis of the experiment.  I 
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used this hive as a control colony to monitor natural mite fall.  Prior to experimentation, I 
placed sticky boards in all hives for a 48 h period to monitor natural mite fall (July 13). 
 
Treatment and data collection   
 I replaced the sticky boards prior to OA application (July 15).  I treated one side 
of the 10 divided hives with 40 mL of a 3.5% OA sugar water solution (sugar:water) 
(1:1) (w:w).  I trickled the OA solution from above the frames between each occupied 
bee-way using a 100 mL syringe and made an effort to maximize contact with the adult 
bee population.  I chose this dose based on a review article for treating colonies with 
minimal capped brood (Rademacher and Harz 2006).  
 I replaced the sticky boards and counted mite fall at 2, 4, and 6 days post-
treatment (July 17, 19, and 21).  I placed a Checkmite® strip in each half-hive to quantify 
remaining mites (July 21) (the experimental mite population had not previously exhibited 
coumaphos resistance).  I replaced sticky boards every 48 hours until no mites were 
detectable (July 23 and 25).  The use of the Checkmite® strips allowed me to quantify the 
total number of mites in each hive prior to OA application.  I added the total number of 
mites recovered 2, 4, and 6 days after OA treatment to the number of mites recovered 
after placing Checkmite® strips in the hives.  This enabled me to calculate the post-
treatment percentage mite fall at 2, 4, and 6 days.   
 
Replication 
 I replicated the entire experiment to increase the power of my tests (September 
2005).  The materials and methods were similar to those listed above.  The only 
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difference was that I did not add queen cells to the hives.  Instead, I allowed the bees to 
rear a queen from a small patch of eggs that I deliberately left when stocking the units.  
Like adding queen cells, allowing the units to rear their own queen ensured that the hives 
would be void of capped brood during experimentation.     
 
Experimental design and statistical analysis 
 I designed my experiment as a split-plot design.  The whole plot factor was 
divider type (single-screen, double-screen, and queen excluder) and the whole plot unit 
was the entire hive.  The split-plot factor was treatment with OA (treated and untreated) 
and the split-plot unit was a half hive.  I used the percentage reduction in Varroa 
infestation 2, 4, and 6 days post-treatment as my response variable.  I blocked by the 
month in which the experiment was conducted (July and September) to account for 
variance in the total mite infestation between the two replicates.   
 I analyzed the data using PROC MIXED (SAS Institute 2006) and I separated 
means using a t-test (α = 0.05).  I assumed random blocks, although the assumption of 
fixed blocks did not change the results.   I used the Kenwood-Rogers degrees of freedom 
adjustment.  I used PROC UNIVARIATE and PROC GPLOT (SAS Institute 2006) to 
verify my assumptions of normality and constant variance.   
 
Results 
Forty eight hour pre-treatment mite fall 
 The 48 h pre-treatment mite fall was 30.4 ± 4.0 mites per split-unit hive in the 
July replicate (n = 20) and 45.8 ± 6.9 mites per split-unit hive in the September replicate 
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(n = 20).  The pre-treatment mite fall was not significantly different for the sides 
scheduled to receive OA versus the sides scheduled to be left untreated for either 
replicate (t = 0.25, df = 36, P = 0.8048). 
 
Total mite infestation 
 The total number of mites recovered per split-unit hive was 389 ± 52 mites (n = 
18) for the July replicate.  The total number of mites recovered per split-unit hive was 
665 ± 52 mites (n = 18) for the September replicate.  The total Varroa infestation in the 
September replicate was 276 ± 73 mites greater per split-unit hive than the July replicate 
(t = 3.76, df = 34, P = 0.0006). 
 
Randomized Complete Block Design (RCBD) split-plot in time 
 My assumptions of normality and constant variance were met.  I used the Shapiro-
Wilk test in the UNIVARIATE procedure of SAS to verify normality.  The Shapiro-Wilk 
test indicated that my data were normal (P = 0.5722).  In addition, a symmetric box-plot 
and a straight-lined normal probability plot confirmed normality.  A plot of the residual 
versus the predicted values revealed no obvious patterns and was indicative of data that 
had constant variance.    
 In total, there were 18 split-unit hives that were sampled at 2, 4, and 6 days post-
treatment (54 observations per replicate).  Fifty-four observations in the July replicate 
plus 54 observations in the September replicate sum to 108 total observations.  The 
response variable was percentage reduction in Varroa infestation.  See Table 6.1 for a 
summary of the F tests for the RCBD split-plot in time effects.   
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 There was significant divider*treatment interaction (P = 0.0001).  The factor 
‘time’ was not part of this interaction so I analyzed the main effect for time.  The time 
effect was significant (P = 0.0001).  There was a 43.1 ± 3.6% (n = 36), 51.4 ± 3.6% (n = 
36) and 58.5 ± 3.6% (n = 36) reduction in Varroa infestation at 2, 4, and 6 days after OA 
application.  The above means represent the average mite fall per split-unit hive 
regardless of divider type or treatment. 
 Significantly more mites fell by day 6 than by days 2 or 4.  Explicitly, 8.4 ± 1.8% 
more mites fell by day 4 versus day 2 (t = 4.73, df = 75, P  = 0.0001), 7.1 ± 1.8% more 
mites fell by day 6 versus day 4 (t = 3.98, df = 75, P = 0.0001), and 15.4 ± 1.8% more 
mites fell by day six versus day 2 (t = 8.71, df = 75, P = 0.0001). 
 
RCBD split-plot on 6 day percentage mite fall 
 The analysis of the RCBD split-plot in time confirmed that it was appropriate to 
only model the 6 day percentage mite fall because more mites fell by day 6 than days 2 
and 4.  To simplify my model, I removed the time factor and used 6 day percentage mite 
fall as the sole response variable in my subsequent data analysis.  This reduced the total 
number of observations from 108 to 36 (108 total observations / 3 time intervals = 36 
observations for 6 day percentage mite fall).  See Table 6.2 for a summary of the F tests 
for the RCBD split-plot on 6 day percentage mite fall.   
 There was significant divider*treatment interaction (P = 0.0001).  I did not 
consider the main effects of divider and treatment because of the significant interaction 
term.  Rather, I analyzed the simple effects to draw conclusions about these two factors.  
Table 6.3 is a summary of the 6 treatment means reported as percentage reduction in 
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Varroa infestation.  Treatment combinations in the divider/treatment column with ‘OA 
treated side’ indicate that OA was applied.  Treatment combinations in the 
divider/treatment column with ‘untreated side’ indicate that OA was not applied.  For 
example, the 6 divided hives with a single-screen divider averaged 73.3 ± 7.5% mite 
reduction on the side that was treated with OA and 22.6 ± 7.5% mite reduction on the 
side that was left untreated.   
 The sides that were treated with OA had significantly more mite fall than the 
untreated sides for all 3 dividers.  When only considering the units with single-screen 
divider, sides that were treated with OA had 50.7 ± 5.4% greater mite fall than the sides 
left untreated (t = 9.33, df = 15, P = 0.0001).  When only considering the units with 
double-screen divider, sides that were treated with OA had 59.6 ± 5.4% greater mite fall 
than the sides left untreated (t = 10.96, df = 15, P = 0.0001).  When only considering the 
units with queen excluder divider, sides that were treated with OA had 15.9 ± 5.4% 
greater mite fall than the sides left untreated (t = 2.92, df = 15, P = 0.0105).   
 There was no difference in the percentage mite fall on the sides that were treated 
with OA for all three dividers.  When only considering the sides that were treated with 
OA; units with double-screen dividers had 4.4 ± 7.8% greater mite fall than units with 
queen excluder dividers (t = 0.55, df = 22.2, P = 0.5849), units with double-screen 
dividers had 11.5 ± 7.8% greater mite fall than units with single-screen dividers (t = 1.46, 
df = 22.2, P = 0.1579), and units with queen excluder dividers had 7.1 ± 7.8% greater 
mite fall than units with single-screen dividers (t = 0.91, df = 22.2, P = 0.3742). 
 When only considering the untreated sides, units with the queen excluder divider 
had significantly more mite fall than units containing either single- or double-screen 
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dividers.  When only considering the untreated sides, units with the queen excluder 
divider had 39.3 ± 7.8% greater mite fall than units containing double-screen dividers (t = 
5.01, df = 22.2, P = 0.0001) and units with the queen excluder divider had 42.0 ± 7.8% 
greater mite fall than units containing single-screen dividers (t = 5.35, df = 22.2, P = 
0.0001).  The percentage mite fall on the untreated sides was not significantly different 
for units containing the single-screen versus the double-screen dividers (t = 0.34, df = 
22.2, P = 0.7403). 
 
Discussion 
I accept my hypothesis that OA kills mites via contact.  Only the queen excluder 
divider permitted worker bees to move freely and allowed physical contact between the 2 
sides.  As Table 6.3 illustrates, bee-to-bee contact was the primary route for OA 
distribution because divided hives with queen excluders had significantly more mite fall 
(65%) on their untreated sides than divided hives with single-screen or double-screen 
dividers.  
 As expected, the percentage mite reduction was not significantly different on the 
sides of the divided hives that were treated with OA regardless of divider type.  My 
intention was to correlate mite fall on the untreated side with divider type.  Divided hives 
with single-screen and double-screen dividers averaged 23 and 25% mite fall on their 
untreated sides after 6 days, respectively.  The 2 control colonies with solid-wood 
dividers (one control per replicate) averaged 29% (n = 2) mite fall on their untreated sides 
after 6 days.  The 29% mite fall on the untreated sides of the control colonies containing 
solid-wood dividers corresponds with the mite fall on the untreated sides of the single-
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screen and double-screen divided hives (23 and 25%).  Trophallactic interactions and 
fumigation did not significantly influence the distribution of OA as single-screen, double-
screen, and solid wood divided hives had similar mite fall on their untreated sides.   
 Significantly more mites fell 6 days after OA application than 2 or 4 days after 
OA application.  This statistic may be interpreted several ways.  One interpretation is that 
OA has residual activity against Varroa for at least 6 days post-treatment.  Another 
interpretation is that a portion of the Varroa mites exposed to OA experience a drawn-out 
death.  My data from chapter 1 and Milani (2001) demonstrate that OA has a high acute 
toxicity to mites in laboratory bioassays 24 hours post-treatment.  Chapter 1 and Milani 
(2001) do not quantify the chronic toxicity of OA to Varroa because of the impossibility 
of sustaining mite populations for long periods of time away from their honey bee hosts.  
Perhaps the chronic toxicity of OA for phoretic mites in the hive environment is 
significantly less than the acute toxicity reported in chapter 1 and Milani (2001). 
 One important assumption of my experiment was that the single-screen divider 
allowed trophallaxis to occur between adult bees on each side.  This assumption held true 
throughout experimentation as I observed adult bees performing proboscis extensions and 
trophallactically interacting between the single-screen dividers.  The role of trophallaxis 
in the distribution of Perizin (coumaphos) in honey bee colonies was investigated by van 
Buren et al. (1992) who divided hives into 3 compartments with screens and traced the 
amount of coumaphos transferred between the sections via trophallaxis.  Although 
trophallactic interactions were of minor importance in the distribution of coumaphos, the 
authors indicate that trophallaxis was occurring between the screened sections of the 
hive. 
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 Anecdotal observations from beekeepers suggest that adult honey bees will ingest 
sugar water feed containing OA.  I noticed small, pea-size pools of the OA sugar water 
solution on the top bars of several hives up to 6 days after OA application.  I did not 
observe ingestion of the OA solution by adult bees and the pools eventually evaporated.  
If the anecdotal observation that bees will ingest sugar water containing OA is true, my 
results suggest that the concentration must be lower than 3.5% OA by weight.  My results 
only apply to the trickle method with a 3.5% OA sugar water solution (1:1) (w:w).  The 
distribution of OA in honey bee colonies when the vaporizer method is used was not 
tested in my study.  My results give beekeepers and researchers insight as to how OA is 
distributed in hives and provide guidance for selecting application techniques that 
maximize the efficacy of OA.   
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Table 6.1 – F tests for RCBD split-plot in time. 
Effect Numeratordf 
Denominator
df F P 
divider 2 14 5.9 0.0142 
treatment 1 75 853.8 0.0001 
divider*treatment 2 75 75.8 0.0001 
time 2 75 38.1 0.0001 
divider*time 4 75 0.9 0.4567 
treatment*time 2 75 0.1 0.8994 
divider*treatment*time 4 75 0.2 0.9341 
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Table 6.2 – F tests for RCBD split-plot on 6 day percentage mite fall. 
Effect Numerator df 
Denominator 
df F P 
divider 2 14 6.8 0.0086 
treatment 1 15 179.6 0.0001 
divider*treatment 2 15 18.0 0.0001 
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Table 6.3 – Percentage reduction in Varroa infestation 6 days post-
treatment.  Estimates with different letters indicate significant 
differences (t-test, α = 0.05). 
Divider type / Treatment Estimate ± Standard Error n    
single screen / oa* treated side 73.3 ± 7.5 a 6 
double screen / oa treated side 84.8 ± 7.5 a 6 
queen excluder / oa treated side 80.5 ± 7.5 a 6 
single screen / untreated side 22.6 ± 7.5 b 6 
double screen / untreated side 25.2 ± 7.5 b 6 
queen excluder / untreated side 64.6 ± 7.5 c 6 
* oxalic acid 
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Figure 6.1 – Left: split-unit Langstroth hive with single-screen divider.  Right: screened 
bottom board with opposing entrances. 
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Figure 6.2 – Left to right: double screen divider and queen excluder divider. 
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